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HOSPITALS, HEALTH CARE PROFESSIONALS, AND AIDS:
THE "RIGHT TO KNOW" THE HEALTH STATUS OF
PROFESSIONALS AND PATIENTS
LARRY GOSTIN $
The acquired immune deficiency syndrome (AIDS) epidemic
has transformed perceptions about the hazards involved in the prac-
tice of medicine, nursing, and associated fields. Documented cases
of transmission of the human immunodeficiency virus (HIV) have
demonstrated that health care professionals (HCPs)l can contract
their patient's lethal infections.'
AIDS, therefore, is increasingly being viewed as an occupa-
tional disease for HCPs,3 despite the evidence that HIV is exceed-
ingly hard to transmit in health care settings.4 For most HCPs this
has not meant, as has often been suggested, an abandonment of
their legal and ethical duties to treat persons with HIV.5 But HCPs,
particularly those who carry out seriously invasive procedures,6
0 Executive Director, American Society of Law and Medicine; Adjunct Associate
Professor of Health Law, Harvard School of Public Health; Associate Director, World
Health Organization/Harvard University International Collaborating Center on Health
Legislation. B.A., State University of New York at Brockport, 1971 (summa cum laude);
J.D., Duke University, 1974. The author is the editor of a volume of essays entitled
"Hospitals, Health Care Professionals, and AIDS" to be published by Yale University
Press.
1. Health care professionals (HCPs) are broadly defined as "persons, including stu-
dents and trainees, whose activities involve contact with patients or with blood or other
body fluids from patients in a health care setting." Centers for Disease Control, Recom-
mendations for Preventing Transmission of HIV in Health-Care Settings, 36 MORBIDrrY & MOR-
TALrY WEEKLY REP. 305, 305 (1987) [hereinafter CDC Recommendations: No. 2S].
2. See Bayer, AIDS and the Duty to Treat: Risk, Responsibility, and Health Care Workers, 64
BULL. N.Y. ACAD. MED. 498, 499 (1988) (citing Friedland & Klein, Transmissions of the
Human Immunodeficiency Virus, 317 NEw ENG. J. MED. 1125, 1127 (1987)).
3. See, e.g., Brennan, Ensuring Adequate Health Care for the Sick: The Challenge of the
Acquired Immunodeficiency Syndrome as an Occupational Disease, 1988 DUKE L.J. 29, 33; Ger-
bert, Maguire, Badner, Altman & Stone, Why Fear Persists: Health Care Professionals and
AIDS, 260J. A.M.A. 3481, 3481 (1988).
4. See, e.g., CDC Recommendations: No. 2S, supra note 1, at 306-07.
5. See infra notes 58-59 and accompanying text.
6. Seriously invasive procedures are distinguished from other medical procedures.
"Seriously invasive procedure" is narrowly defined as "surgical entry into tissues, cavi-
ties or organs or repair of major traumatic injuries," where there is likely to be exposure
to substantial amounts of blood. CDC Recommendations: No. 2S, supra note 1, at 308-09.
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claim the right to know whether their patients are infected with
HIV.7 Their claim is not only to have access to HIV-positive test
results available in the medical records, but to have the right to
screen patients for HIV without their consent.
The Surgeon General has advocated HIV screening of all pre-
operative patients." Some hospitals, irrespective of what the law
may allow, already screen their patients without specific informed
consent.9 There is even a strand of professional opinion that says
specific consent to an HIV test is not required by law, provided
there is consent to the "routine" taking of blood samples.' 0 Other
HCPs concede that it is currently unlawful to test without consent,
but have called for new legislation which would authorize compul-
sory testing and screening of patients." This legal and policy de-
bate has taken place without any analysis of whether the doctrine of
informed consent applies to an HIV test and, more importantly,
whether compulsory testing would be an efficacious policy in imped-
ing the spread of HIV to HCPs.
Patients undergoing seriously invasive procedures also claim
the right to know if their physician is infected with HIV. In a 1987
Gallup Poll, eighty-six percent of those polled said patients should
be told if their physician has AIDS.'" The same poll revealed that
The hepatitis B virus (HBV) experience indicates that only health care workers (HCWs)
who perform seriously invasive procedures have transmitted the HBV to patients. Id. at
317. As the human immunodeficiency virus (HIV) is significantly more difficult to trans-
mit than HBV, it is reasonable to conclude that any limitation-on the right to practice
medicine that may be warranted should be applicable only to seriously invasive
procedures.
7. See, e.g., Foreman, Ethics, Risks Collide in Treatment of AIDS Patients, Boston Globe,
Jan. 31, 1988, at l;Judis, An AIDS Nightmare, N.Y. Times,Jan. 17, 1988, § 6 (Magazine),
at 32; Gordon, HIV Status of Patients of Routine Testing Advocated, AIDS PATIENT CARE, Dec.
1987, at 34; Stayer, Orthopod Urges HIV Testing, Am. Med. News, Dec. 4, 1987, at 36-37.
8. Breo, Dr. Koop Callsfor AIDS Tests Before Surgery, Am. Med. News,June 26, 1987, at
I.
9. See Henry, Willenbring & Crossley, Human Immunodeficiency Virus Antibody Testing:
A Description of Practices and Policies at U.S. Infectious Disease- Teaching Hospitals and Minnesota
Hospitals, 259J. A.M.A. 1819, 1821 (1988) (34% of the United States infectious disease
hospitals and 57% of the Minnesota hospitals estimated that the consent of the patient
was rarely obtained when an HIV test was ordered).
10. See infra notes 131-135 and accompanying text.
1!. See, e.g., AMERICAN COLLEGE OF EMERGENCY PHYSICIANS, AIDS: STATEMENT OF
PRINCIPALS AND INTERMEDIATE RECOMMENDATIONS FOR EMERGENCY DEPARTMENT PER-
SONNEL AND PREHOSPITAL CARE PROVIDERS, reprinted in 17 ANNALS EMERGENCY MED. 1249
(Nov. 1988).
12. See New AHA Guidelines Urge Universal AIDS Precautions, 16 MED. STAFF NEWS 2, 2
(Aug. 1987) ("In a recent poll of 1,000 adults nationwide, conducted [] by SRI Gallup,
80 percent of the respondents said health care workers should be screened for AIDS....
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most patients would choose not to receive treatment from an in-
fected physician. 3 The patients' case has been buttressed by a pol-
icy statement from the American Medical Association (AMA) that a
"physician who knows that he or she is seropositive should not en-
gage in any activity that creates a risk of transmission of the disease
to others."' 4 Presumably this policy would extend to other health
care workers (HCWs), for example, those on a surgical team who
perform seriously invasive procedures. If it is wrong for infected
physicians to invasively treat patients, does this create a correlative
duty on the part of hospitals to screen physicians before they carry
out such treatment?
The prospect of a right to know the health status of both doctor
and patient, with calls for screening on both sides, together with the
potential of litigation for avoidable transmission of HIV, under-
mines trust within the health care system. This article will address
why patients and HCPs with HIV should have autonomy and privacy
rights to choose whether to consent to an HIV test and to disclose
their serologic status. The article will demonstrate that the risk of
HIV transmission in health care settings is exceedingly low, that it is
probably lower than other well-accepted risks taken by patients and
professionals, and that there are other less intrusive ways to further
reduce the risk. The article concludes that knowledge of a patient's
serologic status is unlikely to reduce risk, since no effective action
could be taken with the information. Balanced against the negligi-
ble public health benefit of a right to know are significant personal,
financial, and social costs of screening programs.
HIV status certainly is relevant clinical information and infected
patients should be encouraged to inform their physicians volunta-
rily. Similarly, infected physicians should be encouraged to disclose
the information to their employers who, in turn, should ensure that
the physician poses no meaningful risk to patients.' 5 But to ex-
change this policy of voluntary disclosure for one involving the sys-
and 86 percent said patients should be told if the health care worker caring for them has
AIDS.").
13. See id. (577 of respondents in a nationwide poll said HCWs who have AIDS
should be denied the right to treat patients).
14. Council on Ethical and Judicial Affairs, Ethical Issues Involved in the Growing AIDS
Crisis, 259J. A.M.A. 1360, 1361 (1988) [hereinafter Ethical Issues]. A seropositive test
denotes a showing of the antibody for which the test is administered to detect. See DOR-
LAND'S ILLUSTRATED MEDICAL DICTIONARY 1192 (26th ed. 1985).
15. For a complete discussion of the rights and responsibilities of an HIV-infected
physician, see generally Gostin, HIV-Infected Physicians and the Practice of Seriously Invasive
Procedures, 19 HASTINGS CENTER REP. 32 (1989).
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tematic and mandatory collection of highly intimate data would
trample individual autonomy and privacy rights. 16 It also would sig-
nificantly burden health care providers with financial costs and po-
tential legal liability.
I. OCCUPATIONAL RISKS OF HIV
Numerous studies, all pointing in the same direction, show that
the occupational risk of acquiring HIV in health care settings is ex-
tremely low."7 The risk is most often associated with accidental per-
cutaneous' inoculation of contaminated blood.' 9 For those who do
not sustain needle-stick injuries the risk is negligible.2 0
A. Population Studies
The percentage of HCPs with AIDS (5.4 percent) 2' is compara-
ble to, indeed lower than, the percentage in the work force at large
(5.7 percent).22 Seroprevalence rates for HIV among HCPs without
16. Compare Comment, Prohibiting the Use of the Human Immunodeficiency Virss Antibody
Test by Employers and Insurers, 25 HARV.J. ON LEGiS. 275, 306.08 (1988) (recommending
prohibition of the use of tests for employment purposes) with Comment, The Constitu-
tional Implications of Mandatory AIDS Testing in Health Care Industry, 17 Sw. U.L. REv. 787,
821-22 (1988) (U.S. Constitution does not bar mandatory testing and exclusion of AIDS
carriers from certain positions).
17. See, e.g., Allen, Health Care Workers and the Risk of HIV Transmission, 18 HASTINGS
CENTER REP. 2, 2 (Apr./May 1988); CDC Recommendations: No. 2S, supra note 1, at 306-
07; Centers for Disease Control, Update: Acquired Immunodeficiency Syndrome and Human
Immunodeficiency Virus Infection Among Health-Care Workers, 37 MORBIDITY & MORTALITY
WEEKLY REP. 229, 232 (1988) [hereinafter CDC Update]; Friedland & Klein, Transmission
of the Human Immunodeficiency Virus, 317 NEW ENG. J. MED. 1125, 1131 (1987); Hughes,
Garner, Marcus & Jaffee, AIDS: Epidemiological Lessons from the Health-Care Setting, I I J.
Hosp. INFECTION 209, 215 (1988); Kuhls, Viker, Parris, Carakian, Sullivan-Bolyai &
Cherry, Occupational Risk of HIV, HBV and HSV-2 Infections in Health Care Personnel Caring
for AIDS Patients, 77 AM. J. PuB. HEALTH 1306, 1307 (1987). The first case of an HCP
dying of AIDS was recently reported. It is also the first case of its kind reported from
Latin America, despite the fact that Brazil, Haiti, Mexico, and other countries have re-
ported thousands of cases of AIDS. See deLeon, Sanchez-Mejorada & Zaidi-Jacobson,
AIDS in a Blood Bank Technician in Mexico City, 9 INFECTION CONTROL & Hosp. EPIDEMIOL-
OGY 101, 101-02 (1988) (letter to the editor).
18. "Percutaneous" means passing through unbroken skin. STEDMAN'S MEDICAL
DICTIONARY: LAWYERS' EDITION 1052 (5th ed. 1982).
19. CDC Update, supra note 17, at 232.
20. See Centers for Disease Control, Update: Human Immunodeficiency Virus Infections in
Health-Care Workers Exposed to Blood of Infected Patients, 36 MORBIDITY & MORTALITY
WEEKLY REP. 285, 287 (1987) [hereinafter CDC: HIV in HCWs].
21. CDC Update, supra note 17, at 229.
22. Bureau of Labor Statistics, Employment and Earnings, 35 U.S. Dept. of Labor,
Bureau of Labor Statistics 13, 93, 194 (1988).
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parente'ral23 exposure are comparable to those of American blood
donors.2 4 HCPs, then, do not make up a disproportionate percent-
age of cases of AIDS or HIV.2 5 Further, intensive follow-up investi-
gations by the Centers for Disease Control (CDC) reveal that
approximately ninety-five percent of all cases of AIDS among HCPs
have an identifiable risk.26 These macro-data suggest that occupa-
tional exposure for HCPs is a very insignificant mode of transmis-
sion of HIV.
B. Percutaneous, Surface, and Mucous Membrane Exposure
There have been twenty-five reported cases where HCPs have
been thought to contract HIV in the workplace.27 In most of these
cases HCPs accidentally stuck themselves with contaminated need-
les.28 In a few cases, the HCP had direct contact with infected
blood. 29 The third group of HCPs were providing care to infected
patients, but had no known accident or blood exposure.
23. "Parenteral" refers to the introduction of substances into an organism.
STEDMAN'S MEDICAL DICTIONARY: LAWYERS' EDIION 1031 (5th ed. 1982).
24. Wormser, Joline, Sivak & Arlin, Human lmmunodeficiency Virus Infections: Considera-
tions for Health Care Workers, 64 BULL. N.Y. ACAD. MED. 203, 204 (1988) (citing Shorr,
Berkowitz & Cumming, Prevalence of HTLV-III Antibody in American Blood Donors, 313 NEW
ENG. J. MED. 384, 385 (1985)).
25. Friedland & Klein, supra note 17, at 1131 (as of May 1986, 5.5% of all patients
with AIDS in the United States reported that they were HCPs, and HCPs represented
5.4% of the workforce).
26. Overall, 5.3% of HCPs with AIDS had an undetermined risk. The proportion,
however, appears to be increasing from 1.5% in 1982 to 6.2% in 1987. The proportion
of other AIDS patients with an undetermined risk also has increased over time. CDC
Update, supra note 17, at 230.
27. Telephone interview withJacqueline Polder, Epidemiologist, Hospital Infections
Program, Centers for Disease Control (Feb. 15, 1989).
28. Needlestick Transmission of HTL V-111 from a Patient Infected in Africa. 2 LANcET 1376,
1377 (1984); Neisson-Vernant, Arfi, Mathez, Leibowitch & Monplaisir, Needlestick HIV
Seroconversion in a Nurse, 2 LANCET 814, 814 (1986); Oksenhendler, Harzic, Le Roux,
Rabian & Clauvee, HIV Infection with Seroconversion After a Superficial Needlestick Injury to the
Finger, 435 NEW ENG.J. MED. 582, 582 (1986); Stricof& Morse, HTLV-IlI/LdVSeroconver-
sion Following a Deep Intramuscular Needlestick Injury, 314 NEw ENG. J. MED. 1115, 1115
(1986); Weiss, Saxinger, Rechtman, Grieco, Nadler, Holman, Ginzburg, Groopman,
Goedert, Markham, Gallo, Blattner & Landesman, HTLV-Ill Infection Among Health Care
Workers: Association with Needle-stick Injuries, 254J. A.M.A. 2089, 2090-92 (1985) [hereinaf-
ter Weiss].
29. See CDC: HIV in HCWs, supra note 20, at 285-86 (HCW got blood on her index
finger attempting to insert an arterial catheter into a patient; phlebotomist filling a vac-
uum blood-collection tube was spattered on her face and in her mouth when the top of
the tube flew off; and medical technologist manipulating a blood-separating machine
spilled blood on her hands and forearms).
30. See Centers for Disease Control, Apparent Transmission of Human T.Lymphotropic Vi-
rs Type IlI/Lymphadenopathy Associated Virus from a Child to a Mother Providing Health Care,
[VOL. 48:12
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While the twenty-five reported cases of occupational exposure
to HIV are cause for concern, they nonetheless appear relatively in-
significant given the frequency of contacts between HCPs and HIV-
infected patients."1 Several prospective studies show that even with
a percutaneous exposure to HIV the risk of infection is fairly low.
There is a range of 0.03 to 0.9 percent probability that an HCP will
contract HIV following a documented case of percutaneous (e.g., a
needle-stick or cut) or mucous membrane (e.g., a splash to the eye or
mouth) exposure to HIV-infected blood.3 2 This rate of seroconver-
sion compares favorably with the risk of twelve to seventeen percent
after accidental percutaneous injection from patients with hepatitis
B virus (HBV), even after passive immunization of recipients by im-
mune serum globulin."
The spillage of blood on skin surfaces also is not thought to
pose a significant risk. Three cases of seroconversion of HCPs from
mucous membrane exposures to infected blood, however, demon-
35 MORBIDITY & MORTALITY WEEKLY REP. 76, 76-77 (1986) (mother apparently infected
with the virus while providing her son with nursing care that involved extensive unpro-
tected exposure to the child's infected blood and bodily secretions and excretions).
31. As of December 5, 1988, there were a cumulative total of 79,823 cases of AIDS
reported to the Centers for Disease Control. Centers for Disease Control, United States
Cases Reported to CDC, WEEKLY SURVEILLANCE REP., Dec. 5, 1988, at I. There are
estimated to be between 945,000 and 1.4 million persons infected with HIV. INST. OF
MED., NAT'L ACAD. OF ScI., CONFRONTING AIDS-UPDATE 1988, 49-50 (1988) [hereinaf-
ter CONFRONTING AIDS UPOATE]. Many of those who have serious symptoms of infec-
tion or disease, because they need frequent treatment and care, have had repeated
contact with HCPs.
32. See, e.g., CDC Recommendations: No. 2S, supra note 1, at 306-07; Friedland & Klein,
supra note 17, at 1127 (placing the average level of risk of HIV transmission at 0.76%);
Gerberding, Bryant-LeBlanc, Nelson, Moss, Osmond, Chambers, Carlson, Drew, Levy &
Sande, Risk of Transmitting the Human Immunodeficienty Virus, Cytomegalovirus, and Hepatitis B
Virus to Health Care Workers Exposed to Patients with AIDS and AIDS-Related Conditions, 156J.
INFECrIOUS DISEASES 1, 6 (1987) [hereinafter Gerberding] (less than 1%); Henderson,
Saah, Zak, Kaslow, Lane, Folks, Blackwelder, Schmitt, LaCamera, Masur & Fauci, Risk of
Nosocomial Infection with Human T-Cell Lymphotropic Iirus Type IlIl/Lymphadnopathy-Associ-
ated Virus in a Large Cohort of Intensively Exposed Health Care Workers, 104 ANNALS INTERNAL
MED. 644, 644 (1986) [hereinafter Henderson] (study found 0.56%); Marcus & CDC
Cooperative Needlestick Surveillance Group, Surveillance of Health Care Workers Exposed to
Blood from Patients Infected with the Human Immunodeficiency Virus, 319 NEw ENG. J. MED.
1118, 1119-20 (1988) [hereinafter Marcus] (placing the average level of risk of HIV
transmission at 0.42%); McCray, Occupational Risk of the Acquired Immunodeficiency Syndrome
Among Health Care Workers, 314 NEw ENG. J. MED. 1127, 1131 (1986) (special report of
the Cooperative Needlestick Surveillance Group found 0.72%). But see McEvoy, Porter,
Mortimer, Simmons & Shanson, Prospective Study of Clinical, Laboratory, and Ancillary Staff
with Accidental Exposures to Blood or Other Body Fluids from Patients Infected with HIV, 294 BRIT.
MED. J. 1595, 1596 (1987) (no seroconversions observed in HCWs who had been ex-
posed to HIV).
33. See Friedland & Klein, supra note 17, at 1127.
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strated that HIV can be transmitted through a nonparenteral expo-
sure to blood.3 4 While these cases raised the level of public anxiety,
they all involved substantial exposure to blood where adequate pre-
cautions were not taken.3 5 In each case blood also soaked through
mucous membranes and the HCP had significant breaks in the skin
allowing the virus access.3 6 There is no data quantifying the risk of
surface skin exposure to blood. It is reasonable to assume, however,
that the risk is far less than that caused by an injection of blood from
a contaminated needle." This would place the risk of surface skin
exposure, even to a large amount of blood, well below one
percent.38
C. Biting and Aggressive Behavior
A final possible occupational risk of HIV contraction is from
aggressive behavior of some patients, such as those in emergency
rooms and departments of psychiatry. Here, too, the risk is negligi-
ble. Several follow-up studies of biting revealed no evidence of HIV
transmission.3 9
D. Intimate Caring
The risks to HCPs, then, are almost exclusively through exces-
sive contact with blood and bodily fluids and needle-stick injuries.
If HCPs follow recommended precautions40 when handling bodily
fluids and sharp instruments they will assure a virtually safe work
environment.
The high degree of safety of ordinary contact, or even intimate
caring activities, has been repeatedly demonstrated by major popu-
lation studies of households, dentists, and HCWs in intimate contact
with HIV-infected persons.4 ' Households with an HIV-infected
34. See CDC: HIV in HCWs, supra note 20, at 284-85.
35. Id.
36. Id. at 286-87.
37. Id. at 287.
38. See Friedland & Klein, supra note 17, at 1131.
39. Drummond, Seronegative 18 Months After Being Bitten by a Patient with AIDS, 256J.
A.M.A. 2342, 2342 (1986) (letter to the editor). See also Wahn, Drainer, Voit, Briister,
Scrampical & Scheid, Horizontal Transmission of HIV Infection Between Two Siblings, 2 LANCET
694, 694 (1986) (mother noticed teeth marks on child's arm allegedly caused by infected
sibling, but found no evidence of bleeding).
40. See infra notes 67-78 and accompanying text.
4 1. These studies are reviewed in Friedland & Klein, supra note 17, at 1131-33; Gos-
tin, Curran & Clark, The Case Against Compulsory Casefinding in Controlling AIDS--Testing,
Screening and Reporting, 12 Am.J. L. & MEn. 7, 22-23 (1986).
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member have been studied over a period of years. In these families
there was repeated exposure to saliva: they shared eating utensils,
plates, drinking glasses, and toothbrushes; towels, linens, and
clothes were sometimes soiled with saliva; family members helped
patients to eat and drink; and they kissed on the cheeks and lips.
Involving nearly 500 family members, these studies failed to find a
single case of a family member contracting HIV without some addi-
tional exposure through a blood transfusion, sexual relations, or
perinatal transmission.42
The risk of transmission also has been studied among dental
workers who have had repeated exposures to saliva and blood. In
one study of 1309 dental professionals (72 percent of whom treated
high risk patients and 94 percent of whom reported accidental punc-
ture wounds), only one without a history of behavioral risk factors
for AIDS had HIV.43 That dentist is thought to have contracted
HIV from blood exposure.44 Other studies have not found a single
additional case of transmission to a dentist.45
42. See generally Brettler, Forsberg, Levine, Andrews, Baker & Sullivan, Human Immu-
nodeficiency Virus Isolation Studies and Antibody Testing: Household Contacts and Sexual Partners
of Persons with Hemophilia, 148 ARCHIVES INTERNAL MED. 1299 (1988) (study of 87 house-
hold contacts of 68 HIV antibody-positive hemophilic patients); Fischl, Dickinson, Scott.
Klimas, Fletcher & Parks, Evaluation of Heterosexual Partners, Children, and Household Contacts
of Adults with AIDS, 257 J. A.M.A. 640 (1987) (addressing the spread of the virus in 45
patients with AIDS and their families); Friedland, Saltzman, Rogers, Kahl, Lesser, May-
ers & Klein, Lack of Transmission of HTLV-Ill/LAV Infection to Household Contacts of Patients
with AIDS or AIDS-Related Complex with Oral Candidiasis, 314 NEw ENG. J. MED. 344 (1986)
(determining the risk of transmission to close but nonsexual contacts of 39 AIDS pa-
tients); Jason, McDougal, Dixon, Lawrence, Kennedy, Hilgartner, Aledort & Evatt,
HTLV-III/LAVAntibody and Immune Status of Household Contacts and Sexual Partners of Persons
with Hemophilia, 255 J. A.M.A. 212 (1986) (evaluating the HTLV-1II/LAV antibody and
immune status of 88 persons living with or engaged in sexual relations with 43
hemophiliacs); Lawrence, Jason, Bouhasin, McDougal, Knutsen, Evatt & Joist, HTLV-
Ill/LAV Antibody Status of Spouses and Household Contacts Assisting in Home Infusion of Hemo-
philia Patients, 66 BLOOD 703 (1985) (assessing the prevalences of the virus in a group of
hemophiliacs, their household contacts, and those who assist in home infusions); Mann,
Quinn, Francis, Nzilambi, Bosenge, Bila, McCormick, Ruti, Asila & Curran, Prevalence of
HTLV-Ill/L.V in Household Contacts of Patients with Confirmed AIDS and Controls in Kinshasa.
Zaire, 256J. A.M.A. 721 (1986); Redfield, Markham, Salahuddin, Sarngadharan, Bodner,
Folks, Bollou, Wright & Gallo, Frequent Transmission of HTLV-Ill Among Spouses of Patients
with AIDS-Related Complex and AIDS, 253 J. A.M A. 1571 (1985).
43. Klein, Phelan, Freeman, Schable, Friedland, Treiger & Steigbiigel, Low Occupa-
tional Risk of Human Immunodeficiency Virus Infection Among Dental Professionals, 318 NEW
ENG. J. MED. 86, 88 (1988) [hereinafter Klein). For several letters to the editor in re-
sponse to this article, see 319 NEw ENG. J. MED. 112, 112-14 (1988).
44. Klein, supra note 43, at 88-89.
45. See generally Gerberding, supra note 32, at 8 (no evidence of HIV transmission
from occupational exposure in HCWs, including dentists, at a San Francisco hospital);
Siew, Gruninger & Hojvat, Screening Dentists for HIV and Hepatitis B, 318 NEw ENG. J. MED.
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Similar studies have been done with HCPs who care for HIV-
infected patients.46 These studies also have found no cases of HIV
transmission that were not attributed to accidental needle-stick inju-
ries or mucous membrane exposures to large amounts of blood.
The studies, for example, found no transmission from the exposure
of open wounds to saliva,47 from cardiopulmonary resuscitation,48
or from the performance of invasive procedures with direct expo-
sure to saliva.49
E. Seriously Invasive Procedures
HCPs who carry out seriously invasive procedures, such as sur-
geons, have been in the forefront in calling for a right to know the
serologic status of their patients.5 0 As the analysis of research above
indicates, surgeons face a relatively low risk of HIV transmission.
There have been no documented cases of seroconversion as the re-
sult of a surgical operation. Yet, HCPs who carry out seriously inva-
sive procedures can potentially cut or puncture their skin with sharp
surgical instruments, needles, or bone fragments Studies indicate
that surgeons will cut or puncture a glove in approximately one out
of every four cases"' and will sustain a significant skin cut in one out
of every forty cases.5 2
Despite the high incidence of cut gloves and skin during sur-
gery, the overall risk in operating on an HIV-positive patient re-
mains remote. The prevalence of HIV infection among surgical
patients can be assumed to be the same as for blood donors and
military recruits and personnel, which is between 1 in 10,000 and 15
1400, 1400 (1988) (letter to the editor relating study of 1195 dentists, 84% of whom
reported having received accidental skin punctures, that found no evidence of HIV in-
fection despite exposure to high risk patients).
46. See generally Gerberding, supra note 32; Henderson, supra note 32; Hirsch,
Wormser, Schooley, Ho, Felsenstein, Hopkins, Joline, Duncanson, Samgadharan, Sax-
inger & Gallo, Risk of Nosocomial Infection with Human T-Cell Lymphotropic Virus III (HTLV-
1I1), 312 NEW ENG. J. MED. 1 (1985); McCray, supra note 32; Weiss, supra note 28.
47. McCray, supra note 32, at 1127, 1129.
48. Saviteer, White, Cohen &Jason, HTLV-1Il Exposure During Cardiopulmonary Resus-
citation, 313 NEw ENG. J. MED. 1606, 1606 (1985) (letter to the editor).
49. Gerberding, supra note 32, at 3.
r54 See, e.g., Breo, supra note 8, at 1.
(51) Hagen, Meyer & Pauker, Routine Preoperative Screening for HIV: Does the Risk to the
Surgeon Outweigh the Risk to the Patient?, 259 J. A.M.A. 1357, 1357 (1988) [hereinafter
Hagen] (citing Cruse & Foord, The Epidemiology of Wound Infection: A 10-Year Prospective
Study of 62,939 Wounds, 60 SURGICAL CLINics N. AM. 27 (1980); Furuhashi & Miyamae,
Effect of Pre-Operative Hand Scrubbing and Influence of Pinholes Appearing in Surgical Rubber
i During Operation, 26 BULL. TOxvO MED. DENTAL UNiv. 73 (1979)).
I id. at 1357.
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in 10,000." The risk of infection after a skin puncture with infective
materials is between 3 in 10,000 and 90 in 10,000.11 Given these
data, the risk of contracting HIV in a single surgical operation of an
HIV-infected patient is only in the range of 1 in 130,000 to 1 in
4,500. 55
F. Comparing the Risks of HCPs and Patients
The foregoing analysis shows that HCPs, even those engaged in
seriously invasive procedures, have a very low risk of occupational
exposure to HIV. There has been no scrutiny of transmission of
HIV in the other direction-from HCPs to patients. No such cases
have been recorded, 56 which is not surprising since no systematic
attempt has been made to discover which physicians are HIV-posi-
tive and whether their patients contract HIV.57
This article assumes that the justifications for, and against,
screening patients and HCPs are symmetrical. It is reasonable to
assume that both the HCP and patient run a very small risk of trans-
mission of HIV in health care settings. While this article contends
that neither patient nor HCP has a valid claim for a right to know, it
is important to stress that both groups possess strong arguments in
favor of screening.
HCPs can argu.e that they run a relatively greater risk of con-
tracting HIV than do their patients. They can point to the absence
of any recorded case of HIV transmission from an HCP to a patient.
An HCP clearly is more likely to sustain parenteral or mucous mem-
brane exposures to HIV, which are the chief occupational causes of
transmission. Surgeons or other HCPs performing seriously inva-
sive procedures are likely to be exposed to a large quantity of con-
taminated tissue in the operative field. Patients, on the other hand,
will be exposed to little, if any, blood from surgeons who cut or
puncture themselves.
The patient has an equally compelling claim that his or her
right to-know takes precedence over the physician's. The surgeon's
significant contact with the patient's blood and organs, together
53. Id. at 1358 (footnotes omitted).
54. Id.
55. Hagen, supra note 51, at 1358.
56. CDC Recommendations: No. 2S, supra note 1, at 317.
57. But see Sacks, AIDS in a Surgeon, 313 NEw ENG.J. MED. 1017, 1017 (1985) (letter
to the editor relating case of HIV-infected surgeon who operated on 400 patients be-
tween 1978 and 1983 without a report of HIV transmission).
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with the high rate of torn gloves, makes it reasonable to assume that
the risk runs in both directions.
Even if the patient's risk during a single operation is lower than
that of the surgeon, the cumulative risk to surgical patients arguably
is higher. While an HIV-infected patient is likely to have few seri-
ously invasive procedures, the infected surgeon, even if the virus
drastically shortens his or her surgical career, can be expected to
perform between 100 and 500 operations. Even if one assumes that
the risk of contracting HIV from an infected surgeon were at the low
end of the range of risk discussed previously (1 in 130,000), then the
cumulative risk that one of the surgeon's patients will contract HIV
would still be much more realistic-i in 1,300 (assuming 100 opera-
tions) to I in 260 (assuming 500 operations).
Information about a person's serologic status is necessary only
if some action would be taken to reduce the risk of transmission that
would not be taken if the information were unavailable. Informa-
tion that a patient is HIV-positive is of very limited use to the physi-
cian since physicians have a professional,58 if not a legal,5 9
responsibility to treat infected patients. Usually it is not possible to
utilize different methods for treating HIV-positive patients to reduce
the risk of contracting the infection; and in some cases different
methods could result in prolongation of operative time, potentially
having an adverse effect on the patient.6" Further, the CDC 6 ' and
the Occupational Safety and Health Administration (OSHA)62 rec-
ommend the universal application of barrier protection in all cases
of exposure to blood. Information that a patient is HIV-positive
should not significantly affect the precautions taken in most cases. 6,
58. See Ethical Issues, supra note 14, at 1360 ("a physician may not ethically refuse to
treat a patient whose condition is within the physician's current realm of competence
solely because the patient is seropositive").
59. See Annas, Not Saints, But Healers: The Legal Duties of Health Care Professionals in the
AIDS Epidemic, 78 AM.J. PuB. HEALTH 844, 848 (1988) (suggesting that health care prov-
iders in private practice have no legal duty to treat, except in specific situations dictated
by statutory, common law, or contractual obligations).
60. CDC Recommendations: No. 2S, supra note 1, at 317.
61. Id. at 308. The CDC recommends that gloves, masks, protective eyewear, and
gowns be worn depending on the procedure to be performed and the likelihood that
such procedure will generate contact with blood or other bodily fluid. Id.
62. 52 Fed. Reg. 41,818, 41,821 (1987) (joint advisory notice of the Department of
Labor and the Department of Health and Human Services (DHHS) concerning protec-
tion against occupational exposures to HBV and HIV). Barriers in the form of engi-
neering controls, work practices, and protective equipment are required. Id. at 41,820.
63. Gerberding, Recommended Infection-Control Policies for Patients with Human Immu-
nodeficiency Virus Infection: An Update, 315 NEw ENG. J. MED. 1562, 1563 (1987) (special
report of the University of California, San Francisco task force on AIDS). After review-
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Patients, on the other hand, clearly would act upon the knowl-
edge that their physicians were infected with HIV. "Information that
their physician is seropositive, at least in the subjective view of most
patients, is highly relevant to the treatment decisions patients must
make. A patient usually has a choice of physicians, and many would
not choose a physician who is infected with HIV."
The purpose of this article is not to compare the respective
claims of patients and HCPs to a right to know the serologic status
of the other. Pitting the HCP and patient against one another in this
way is singularly unhelpful. Rather, this article dwells on the com-
parison between risks, rights, and responsibilities of patients and
HCPs for one reason: It is inherently likely that public policy would
favor compulsory screening of patients, particularly those undergo-
ing seriously invasive procedures, over compulsory screening of
HCPs. This is likely both because HCPs often have more influence
over the political process and because it is administratively more
likely that patients will be tested for HIV during the course of per-
forming routine blood tests. If HCPs assert a justification for test-
ing patients for HIV without consent, it is reasonable to ask why that
same justification does not apply equally, or at least substantially, to
HCPs. Rather than pit the patient and HCP against one another,
this article argues that HIV transmission for either patient or HCP is
far too low to justify the personal and financial costs of systematic
screening.
G. Relative Risk and the Perception of Risk
HCPs, by the nature of their profession, incur some risk of con-
tracting infections from their patients. But the risks they incur from
HIV are no greater, and probably less, than the risks from other
contagious conditions or occupational hazards. HBV, not HIV, is
the major occupational health hazard in the health care industry.
The CDC estimates that 500 to 600 HCPs whose jobs entail expo-
ing the principles of infection control for the prevention of HIV transmission, the task
force concluded that these principles did not differ from those underlying the standard
procedures recommended for any patient. Id. The task force concluded, therefore, that
the special infection-control precautions for patients known to be infected with HIV are
unnecessary in most health care settings. Id. But cf. Gerberding, Infection-Control Policies
and AIDS, 316 NEw ENG. J. MED. 1480, 1480 (1987) (letter to the editor advocating
universal compliance with CDC infection- control guidelines, while recognizing the diffi-
culties of enforcement).
64. See supra notes 12-13 and accompanying text. For an in-depth analysis of the
issue of a patient's right to know the serologic status of the physician, see generally
Gostin, supra note 15.
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sure to blood are hospitalized annually with HBV infections, and
over 200 of those hospitalized die from the virus.6" Studies indicate
that ten to forty percent of all health care or dental professionals
show serologic evidence of past or current HBV infection.66
The risks of HIV perceived by HCPs are distorted because of
the high mortality of AIDS: the odds of contracting HIV are decid-
edly low but the consequences are severe. The risks also are dis-
torted by societal perceptions of AIDS and its victims. It is not only
that AIDS is a lethal disease; it also engenders social prejudice and
irrational fear.
We like to believe that HCPs can view the disease with scientific
detachment, immune from the prevailing fear and prejudice in soci-
ety. As scientists, HCPs should recognize that they cannot expect to
eliminate all risk. Provided the level of risk is within acceptable lim-
its, it has to be accepted as a part of the ethical responsibilities of
treating and caring for patients.
The goals then for HCPs, as for the public at large, are twofold:
to educate HCPs about the fact that the risks of contracting HIV,
while real, are well within the boundaries of other acceptable risks;
and to train HCPs to take every precaution in handling the blood
and bodily fluids of any patient to truly minimize the risk. These
precautions are discussed next.
II. REDUCING THE OCCUPATIONAL RISKS OF HIV
The argument developed in this article against a right to know
the patient's serologic status is not simply that the risk of HIV trans-
mission is exceedingly low, but that it can be reduced even further
without the need for testing. As early as 1985 the CDC recom-
mended that blood and bodily fluid precautions be used consistently
for all patients.6 This approach, referred to as universal blood and
body fluid precautions or universal precautions, should be used in
the care of all patients, including those in emergency settings in
which the risk of blood exposure is increased and the infection sta-
65. 52 Fed. Reg. 41,818, 41,818 (1987).
66. Palmer, Barash, King & Neil, Hepatitis Among Hospital Employees, 138 W.J. MED.
519, 520 (1983).
67. Centers for Disease Control, Recommendations for Preventing Transmission of Infection
with Human T-Lymphotropic Virus Type Ill/Lymphadtnopathy-Associated Virus in the Workplace,
34 MORBIDTY & MORTALITY WEEKLY REP. 681, 682-83 (1985) [hereinafter CDC: Prevent.
ing Transmission in the Workplace]. See also Centers for Disease Control, Recommendations for
Preventing Transmission of Infection with Human T-Lymphotropic Virus Type
lIl/Lymphadenopathy-Associated Virtu During Invasive Procedures, 35 MORBIDITY & MORTALITY
WEEKLY REP. 221, 221-23 (1986).
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tus of the patient usually is unknown.6"
The universal precautions recommended by the CDC have a
number of specifications. 9 First, all HCPs should routinely use ap-
propriate barrier protection to prevent skin and mucous membrane
exposure when contact with blood or other bodily fluids is antici-
pated. Gloves should be worn for touching blood and bodily fluids
and for performing venipuncture; masks and protective eyewear
should be worn during procedures that are likely to generate drop-
lets of blood; gowns or aprons should be worn during procedures
that are likely to generate splashes of blood.70 Second, hands and
other skin surfaces should be washed immediately and thor-
oughly. 7' Third, all HCPs should take precautions to prevent injury
caused by needles, scalpels, or other sharp instruments. Detailed
advice is given on avoiding manipulation of sharp implements by
hand and for disposal in puncture-resistant containers.72 Fourth,
HCPs with exudative lesions or weeping dermatitis should refrain
from all direct patient care.73
In addition to these universal precautions the CDC recom-
mends special precautions for invasive procedures, dentists, autop-
sies or morticians' services, and laboratories. 74 Guidelines for
environmental hazards also are given. 75 The CDC updated its rec-
ommendations in June 1988 by detailing the bodily fluids to which
universal precautions do 76 and do not 77 apply.
78
68. See Baker, Kelen, Sivertson & Quinn, Unsuspected Human Immunodeficiency Virus in
Critically Ill Emergency Patients, 257 J. A.M.A. 2609, 2609 (1987). The FDA recently ap-
proved a test for HIV antibodies that can be performed in only five minutes and does
not require sophisticated equipment. The new test, Recombigen HIV-1 Latex Aggluti-
nation, uses an engineered protein and microscopic beads to detect antibodies to HIV.
Five-Minute AIDS Test Is Approved by FDA, N.Y. Times, Dec. 14, 1988, at 21. col. 1.




73. CDC Recommendations: No. 2S, supra note 1, at 308.
74. See Neslund, Matthews & Curran, The Role of CDC in the Development ofJAIDS Recom-
mendations, 15 LAW, MED. & HEALTH CARE 73, 73-74, 76-77 (1987).
75. Id. at 77; Centers for Disease Control, CDC Guidelines for the Prevention and Control
of Nosocomial Infections: Guidelinefor Prevention of Surgical Wound Infections, 1985, 14 AM. J.
INFEMcION CorROL 71, 78 (1986).
76. Blood is the single most important source of HIV, HBV. and other blood-borne
pathogens in occupational settings. Centers for Disease Control, Update: Universal Pre-
cautions for Prevention of Transmission of the Human Immunodeficiency Virus, Hepatitis B Virus and
Other Bloodborn Pathogens in Health-Care Settings, 37 MORBIDTrr & MORTALITY WEEKLY REP.
377, 378 (1988). Universal precautions, therefore, apply to blood and other bodily
fluids containing visible blood. Id. They also apply to semen, vaginal secretions, cer-
ebrospinal fluid, synovial fluid, pluvial fluid, peritoneal fluid, and amniotic fluid. Id.
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Although they could be used to set a professional standard of
care in any future actions for negligence against hospitals or HCPs,
the CDC guidelines have no actual regulatory effect.79 The Depart-
ment of Labor and the Department of Health and Human Services
(DHHS), however, issued ajoint advisory notice on occupational ex-
posure to HIV and HBV.8 0 The notice is applicable to any worker
who has a "predictable job-related requirement" that may involve
exposure to blood or bodily fluids-primarily HCPs and "first re-
sponse" emergency workers."' OSHA has given advance notice of
proposed rulemaking in order to protect workers from the risk of
blood-borne diseases."2 OSHA has already begun inspections to ex-
amine actual workplace compliance with the joint advisory notice.8 3
Recently, the Department of Labor issued the draft version of
proposed regulations. Although not yet finalized, these draft pro-
posed rules would closely follow CDC guidelines. Under the draft
proposed regulations, workers would be required to handle all
blood and bodily fluids as if the fluids were infected. Hospitals and
health care employers would be required to identify workers who
could be exposed to infectious materials and provide them with
gloves, gowns, masks, and other protective clothing. Health care
employers also would have to ensure that protective items were
used appropriately. Employers would be responsible for compul-
sory employee training concerning the ways blood-borne diseases
are transmitted and the safe handling of infectious material. Under
the draft proposed regulations, hospital and other employers who
fail to comply with the standards would be subject to penalties."
Public health, 5 professional, 6 and regulatory 7 bodies have
77. Universal precautions do not apply to feces, nasal secretions, sputum, sweat,
tears, urine, and vomitus unless they contain visible blood. Id.
78. Id. at 378-79.
79. See generally Hermann, Liability Related to Diagnosis and Transmission of AIDS, 15
LAw, MED. & HEALTH CARE 36, 38 (1987) (blood supplier that complied with CDC rec-
ommendations for testing should be found to have met reasonable standard of care).
80. 52 Fed. Reg. 41,818 (1987).
81. Id. at 41,820.
82. 52 Fed. Reg. 45,438 (1987).
83. A Connecticut hospital was cited by OSHA for failing to adequately protect em-
ployees against the spread of blood-borne diseases. 73 Daily Lab. Rep. A-I, at I (Apr.
15, 1988) (WESTLAW, BNA-DLR database).
84. Occupational Safety & Health Admin, Draft of OSHA Proposed Standard for
Bloodborne Pathogens (Jan. 9, 1989). See also 52 Fed. Reg. 41,818 (1987).
85. See, e.g., CDC Recommendations: No. 2S, supra note 1, at 307-09; PRESIDENTIAL
COMM'N ON THE HUMAN IMMUNODEFICIENCY VIRUS EPIDEMIC, REPORT OF THE PRESIDEN-
TIAL COMMISSION ON THE HUMAN IMMUNODEFICIENCY VIRUS EPIDEMIC 34 (June 1988)
[hereinafter PRESIDENT'S COMM'N] (Recommendation 3-42 states that "[a]ll institutions
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supported universal precautions as the preferred policy response to
impede the spread of HIV in health care settings. Documented ser-
oconversion has occurred almost exclusively after direct contact
with blood or bloody bodily fluids, either through needle-stick in-jury or by exposure of a mucous membrane or non-intact skin.8
Barrier protection against spillage or splattering of blood would vir-
tually eliminate nonpercutaneous exposure.
Needle-stick injury is likely to remain the most important risk
event for HCPs. Yet, these preventable accidents remain com-
mon.89 The rate of needle-stick injuries is gradually being lowered
with the use of precautions, but still there are far too many.90
A. Proposals for the Enforcement of Universal Precautions
The fact is that there continues to be significant noncompliance
with CDC guidelines and other infection-control measures. 9' One
major reason for noncompliance is that it is difficult to convince
HCPs in low prevalence areas to regard everyone as seropositive
when few are.9" Even when HCPs do comply with the guidelines,
they often must use essential equipment such as gowns, goggles,
and agencies employing health care workers should require adherence to Universal Pre-
cautions or other infection control procedures in performance standards and in workers'
evaluations.").
86. See, eg., Health & Pub. Pol'y Comm. of the Am. Co. of Physicians & Infectious
Diseases Soc. of Am., The Acquired lmmunodeflcienuy Syndrome (AIDS) and Infection with the
Human Immunodeficiency Virus (HIV), 108 ANNALS INTERNAL MED. 460, 462 (1988) [herein-
after Am. Co. of Physicians] ("substantial data indicate the effectiveness of such barrier
techniques in preventing transmission of hepatitis B"); Letter from the AM. Hosp. Ass'N,
AIDS/HIV INFECTION POLICY: ENSURING A SAFE HOSPITAL ENVIRONMENT ii (Nov. 1987)[hereinafter AHA REP.] ("Because it is often not possible to know when an individual
may be infected with the HIV, consistent use of a barrier to reduce the chances of direct
contact with potentially infected blood and body substances is the best way to avoid
accidental exposure to HIV infection.").
87. See supra notes 80-84 and accompanying text.
88. Wormser, Rabkin & Joline, Frequency of Nosocomial Transmission of HIV InfectionAmong Health Care Workers, 319 NEw ENG.J. MED. 307, 307 (1988) [hereinafter Wormser](footnotes omitted).
89. Jagger, Hunt, Brand-Elnaggar & Pearsoh, Rates of Needlestick Injuy Caused by Vari-
ou Devices in a University Hospital, 319 NEw ENG.J. MED. 284, 285-86 (1988) [hereinafter
Jagger]; Oksenhender, Harzic, LeRoux & Claurel, HIV Infection with Seroconversion after aSuperficial Needlestick Injury to the Finger, 315 NEw ENG. J. MED. 582, 582 (1986) (letter to
the editor); Wormser, supra note 88, at 307.
90. See Wormser, supra note 88, at 307-08. See also Neuberger, Harris, Kundin, Bis-
chone & Chin, Incidence of Needlestick Injuries in Hospital Personnel" Implications for Prevention,
12 AM.J. INFECTION CON'TROL 171, 174-76 (1984).
91. Greene, Infection Control Policies and AIDS, 316 NEw ENG. J. MED. 1479, 1479(1987) (letter to the editor).
92. Id.
MARYLAND LAW REVIEW
and shoe covers that have not been inspected, and deal with pro-
curement procedures designed to purchase the least expensive
equipment without consideration for quality or effectiveness.93
Moreover, much of the equipment is simply poorly designed:
gloves do not resist punctures and disposable needles cannot be dis-
posed of safely.94
A number of methods could be used to encourage, or require,
HCPs to adopt universal precautions'; other methods could be used
to ensure HCPs of high quality equipment. First, states could re-
quire, perhaps through their professional accreditation bodies, par-
ticipation in appropriate education programs and certification in
infection-control knowledge.9 5 Second, OSHA or the Joint Com-
mission on Accreditation of Hospitals (JCAHO) could require all
health care facilities to make high quality infection-control devices
and supplies available in all patient areas.96 Third, new designs for
equipment could provide a safer environment for HCPs. Needle-
stick injuries, for example, could be significantly reduced by designs
that allow the HCP's hands to remain behind the needle as it is cov-
ered, the needle to be covered before disassembly of the device, and
the needle to remain covered after disposal.97 Other design im-
provements would include puncture-resistant gloves and more flexi-
ble and impervious barrier protection for the feet, hands, and face. 98
Finally, the Department of Labor and Health and the DHHS
could systematically enforce the requirements for universal precau-
tions through periodic inspections of all hospitals across the coun-
try. These proposals would undoubtedly be difficult and expensive
to implement. But they hold out the best prospect for lowering oc-
cupational risks of HIV as well as all other major blood-borne
diseasei.
The primary alternative to universal precautions, often vehe-
mently proposed, is routine HIV screening of patients, with precau-
93. See PRESIDENT'S COMM'N, supra note 85, at 31.
94. Address by James Luck, 55th Annual Meeting of the American Academy of
Orthopaedic Surgeons, in 36 BuLL. AM. ACAD. ORTHOPAEDIC SURGERY (Supp. July 1988)
(discussing methods of minimizing risks of HIV transmission in orthopaedics).
95. See PRESIDENT'S COMM'N, supra note 85, at 34 (recommendation 3-41). Florida
already has passed a law requiring physicians to receive special training in infection con-
trol. See Gostin, Public Health Strategies for Confronting AIDS: Legislative and Regulatory Policy
in the United States, 261 J. A.M.A. no. 11 (forthcoming March 17, 1989).
96. See PRESIDENT'S COMM'N. supra note 85, at 34 (recommendation 3-43).
97. Jagger, supra note 89, at 284; see Kempen, Equipment Modifications to Reduce Needle
Sticks, 319 NEw ENG. J. MED. 308, 308 (1988) (letter to the editor).
98. Address by James Luck, supra note 94.
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tions used only for those who test positive. This article now will
address the reasons why such a policy would be inefficacious.
B. Selective Precautions for Patients Who Test HIV-Positive
Despite the consensus on the need for universal precautions,
many at least implicitly argue that the precautions are unnecessarily
expensive and impractical.9" If HCPs were able to test routinely for
HIV, the argument goes, precautions could be limited to those cases
where the patient tested HIV-positive.
Implicit in this argument is a presumption that if a patient tests
positive HCPs can take special precautions which they otherwise
would not have taken, and that those special precautions will reduce
the occupational risks of HIV. The evidence, however, does not
support such a presumption: in the overwhelming majority of occu-
pational transmission cases, the HCP already knew the patient was
HIV-positive. ° ° Indeed, knowledge that a patient is HIV-positive
may well increase the occupational risk to HCPs, perhaps because
the HCP is overly conscious of the threat of HIV and thus becomes
hesitant and awkward.' 0 '
Rather than using special precautions only when a patient tests
HIV-positive, HCPs should employ appropriate precautions when-
ever they anticipate contact with blood or bodily fluids, irrespective
of the patient's serologic status. Failure to do so may result in a
false sense of security if the patient tests negative. If HCPs, relying
upon negative test results, do not take appropriate precautions, they
greatly increase their chances of infection. Current HIV tests are
imperfect.' 02 They detect antibodies to the virus, not the virus it-
self. Characteristically, the body will not produce antibodies for
weeks after infection.10 3 In some cases there will be no detectable
antibodies for up to fourteen months.'0 4 Although these infected
99. See, e.g., Carey, Guido & Wiener, Routine Preoperative Screening for HI', 260 J,
A.M.A. 179-81 (1988) (letters to the editor).
100. See supra notes 27-38 and accompanying text.
101. In one medical center in New York City, I out of every 10 reported needle-stick
accidents occurred in the course of caring for an HIV-infected patient. Krasinski,
LaCouture & Holzman, Effect of Changing Needle Disposal Systems on Needle Puncture Injuries,
8 INFECTION CONTROL 59, 61 (1987). In a different New York City medical center, at
least 7% of 440 house officers had percutaneous exposures when caring for patients
with AIDS. Weiss, supra note 28, at 2090.
102. HIV tests produce a small number of false negative results-usually under 1%.
For an examination of the technical aspects of these tests, see infra note 109.
103. Mueller, The Epidemiology of Human Immunodeficiency Virus Infection, 14 LAw, MED. &
HEALTH CARE 250, 253-54 (1986).
104. Id.
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patients produce no antibodies and test negative, they still will be
infectious and capable of transmitting the virus."0 5 Thus, reliance
on an antibody test result for the purpose of using selective precau-
tions is a dangerous practice that probably increases the risk of HIV
transmission.
Reliance on HIV antibody screening also increases the risk of
transmission of other blood-borne diseases. A different strain of
HIV already exists in Africa and, in rare cases, in the United
States.' 6 As discussed above, HBV is very prevalent in health care
settings.' 0 7  Other blood-borne diseases, including those now
known to cause certain human cancers, also are transmissible in hos-
pitals. 10 Health care environments cannot be made safer by relying
on imperfect technology designed to screen out infectious from
noninfectious patients. In the long run, HCPs can protect them-
selves only by assuming that all blood and bodily fluids may be con-
taminated with some infectious agent, and by taking appropriate
precautions.
Even if screening in health care settings were shown to be effi-
cacious in impeding the spread of HIV, the personal, social, and fi-
nancial costs of screening would be prohibitive.
III. INFORMED CONSENT TO HIV TESTING: DEFENDING THE
PATIENT'S AUTONOMY AND PRIVACY
The HIV antibody test, the Enzyme Linked Immunosorbent As-
say (ELISA), perhaps greater than any other procedure in modern
medical history, has stirred controversy: while it is a relatively accu-
rate test, it does generate a significant number of false positive re-
sults when administered to a low prevalence population.10 9 In
105. Id.
106. Address by David Bell, 55th Annual Meeting of the American Academy of
Orthopaedic Surgeons, in 36 BULL. AM. ACAD. ORTHOPAEDIC SURGERY (Supp.July 1988)
(discussing the risks of HIV transmission in the health care setting and methods of
prevention).
107. See supra notes 65-66 and accompanying text.
108. Address by David Bell, supra note 106.
109. The current test to detect HIV antibodies is the Enzyme Linked Immunosorbent
Assay (ELISA). A person is identified as HIV-positive when a sequence of tests, starting
with repeated ELISAs and including a confirmatory test such as the Western Blot, are
repeatedly reactive. The ELISA, in fact, is one of the most accurate of all medical tests,
with a sensitivity and specificity of at least 99%, when performed under optimal labora-
tory conditions. CDC Recommendations: No. 2S, supra note 1, at 315. See Burke, Brun-
dage, Redfield, Damato, Schoble, Putman, Visintire & Kim, Measurement of the False
Positive Rate in a Screening Program for Human Immunodeficiency Virus Infections, 319 N. ENG. J.
MED. 961, 962 (1988). ELISA's bad reputation came from earlier versions where its
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addition, a positive test result itself engenders irrational fear and
prejudice" 0 and is perceived to have no potential benefit for the
patient because no curative treatment exists."' This anti-testing
bias is seen repeatedly in the opposition by high risk group mem-
bers to widespread testing."12
HIV testing, however, takes many different forms and is done
for many different reasons. The patient and others can benefit from
HIV testing. But since that benefit is often equivocal, and since
there are many potentially adverse personal and social effects, the
decision must rest with the patient. The chief purpose of this sec-
tion is to show why, as a matter of law and ethics, informed consent
should always be obtained prior to an HIV test."I3 The one excep-
predictive value was lower. It also came from the application of the ELISA to low preva-
lence populations, such as blood donors. See Cleary, Barry, Mayer, Brandt, Gostin &
Fineberg,'Compulsory Premarital Screening for the Human Immunodeficiency Virus-Technical and
Public Health Considerations, 258J. A.M.A. 1757, 1758-59 (1987); Meyer & Pauker, Screen-
ing for HI'- Can We Afford the False Positive Rate?, 317 NEw ENG. J. MED. 238, 239-40
(1987). Even the best scientific tests have a significant false positive rate in low preva-
lence populations. See Barry, Cleary & Fineberg, Screening for HIV Infection: Risks, Benefits
and the Burden of Proof, 14 LAw, MED. & HEALTH CARE 259, 262-63 (1986). Tests to detect
the virus directly are now being developed which would overcome most of the techno-
logical problems with the test. For a more complete explanation of the technical aspects
of screening, see Gostin, Curran & Clark, supra note 41, at 10-13. See generally Centers
for Disease Control, Update: Serologic Testing for Antibody to Human Immunodeficiency Virus,
36 MORBIDrrY & MORTALITY WEEKLY REP. 833 (1988); Schwartz, Dans & Kinosian,
Human Immunodefucieny Virus Test Evaluation, Performance and Use, 259 J. A.M.A. 2574
(1988).
110. Public opinion polls have consistently shown that a significant minority of people
believe that HIV-positive persons should not be permitted in ordinary schools.jobs, and
public housing. Others believe they deserve the "punishment" they are receiving. See
Blendon & Donelan, Discrimination Against People with AIDS: The Public's Perspective, 319
NEw ENG.J. MED. 1022, 1023-25 (1988).
111. For a review of prospects for antiviral drugs for HIV, see Macklin & Friedland,
AIDS Research: The Ethics of Clinical Trials, 14 LAw, MED. & HEALTH CARE 273, 274-75
(1986). See generally Glatt, Chirgwin & Landesman, Treatment of Infections Associated with
Human Immunodeficiency Virus, 318 NEw ENG. J. MED. 1439 (1988); Young, Promoting Drug
Development Against AIDS and the HIV Infection, 43 FOOD DRUG COSM. LJ. 215 (1988).
112. See R. BAYER, PRIvATE ACTS, SOCIAL CONSEQUENCES: AIDS AND THE POLITICS OF
PUBLIC HEALTH (1989).
113. See generally Closen, Connor, Kaufman & Wojik, AIDS: Testing Democracy-Irra-
tional Responses to the Public Health Crisis and the Need for Privacy in Serologic Testing, 19 J.
MARSHALL L. REv. 835 (1986); Gostin, Curran & Clark, supra note 41; Swartz, AIDS Test-
ing and Informed Consent, 13J. HEALTH POLITICS POLICY & LAw 607 (1988), Comment, The
Constitutional Implications of AIDS Testing in the Health Care Industry, 17 SW. U.L. REv. 787
(1988). This section will discuss the general common-law requirements to obtain in-
formed consent to HIV testing. In addition, several states have enacted statutes that
specifically require informed consent for an HIV test, among them California, Colorado,
Hawaii, Illinois, Indiana, Kentucky, Maine, Massachusetts, Oregon, Washington, and
Wisconsin. See, e.g., CAL. HEALTH & SAFETY CODE § 199.22(a) (West 1988). See also Gos-
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tion is blind epidemiologic screening where the patient's identity
cannot be ascertained.' 14
A. Voluntary Testing
Testing for HIV in health care settings after obtaining the in-
formed consent of the patient poses no significant legal or ethical
difficulties because the decision rests ultimately with the subject of
the test. The CDC recommends testing with the informed consent
of patients for: (1) patient diagnosis and management, (2) manage-
ment of parenteral or mucous membrane exposures of HCPs, and
(3) counseling and serologic testing to prevent and control HIV
transmission in the community." 5 Clearly, the testing objectives for
each of these categories are very different: the rationales for the test
may be to benefit the patient, the HCP, or the welfare of others in
the community.
Most patients would consent to an HIV test if they knew it
tin, supra note 95. Typically these statutes prohibit HIV tests without a document signed
by the one to be tested giving consent, after that person has been informed and coun-
seled about the motive and purpose of the test, as well as the personal and social ramifi-
cations. Id. In some states, such as Alabama, California, Colorado, and Washington,
mature minors can give informed consent without parental agreement. Id.
114. The CDC has recommended that hospitals, in conjunction with state and local
health departments, should periodically determine the prevalence of HIV infection
among patients from age groups at the highest risk of infection. Centers for Disease
Control, Public Health Service Guidelines for Counseling and Antibody Testing to Prevent HIV
Infection and AIDS, 36 MORBIDITY & MORTALITY WEEKLY REP. 509, 513 (1987) [hereinaf-
ter CDC Recommendations: Testing]. The Public Health Service does not seek informed
consent from patients prior to blind epidemiologic screening. Patients' blood is tested,
however, without any means to identify the name of the patient. Such blind epidemio-
logic screening has been supported by the World Health Organization. World Health
Organization, Report of the Meeting on Criteria for HIV Screening Programmes,
WHO/SPA/GLO/87.2 (May 20-21, 1987) (hereinafter WHO Criteria for HIV Screen-
ing]. The rationale for screening without consent is that the epidemiologic studies pro-
vide essential data on prevalence and trends of HIV in various populations. Since
patients are not identified, there are few, if any, infringements on their rights to privacy
or autonomy.
Great Britain is one of the few countries in the world that explicitly reject anony-
mous screening as ethically unjustifiable. The view of the British government is that
such screening is an abandonment of care by the physician if there are no means to
inform a patient that he or she is HIV-positive. Legal commentators in Britain also have
suggested that patients have a right to know, and to consent to use of their blood for
specific purposes.
One way to improve the situation in the United States would be to inform patients
that the hospital will conduct blind epidemiologic research with their blood. This fore-
warns patients not to enter the hospital if they disapprove of screening. Scientists per-
forming blind epidemiologic screening, however, could not seek consent from each
patient because the knowledge would bias the study.
115. CDC Recommendations: No. 2S, supra note 1, at 316.
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would benefit others. These patients, however, must receive full in-
formation that accurately states the reasons for the test. The in-
formed consent form that patients sign also should explain the
performance, the meaning, and the benefits of the test, as well as the
physical, personal, financial, and social risks of being tested. Accu-
rately informing patients of the true reasons for the test is ethically
importint. Patients may reasonably assume that all tests are per-
formed in their interests unless otherwise specified." 6 HCPs would
be obtaining consent by misrepresentation if they did not fairly and
accurately disclose to patients that they actually were being tested to
safeguard the health of HCPs or others.
1. Patient Diagnosis and Management.-The CDC recommends
HIV testing as "a useful diagnostic tool for evaluating patients with
selected clinical signs and symptoms" associated with HIV dis-
ease." 7 Use of an HIV test for diagnostic purposes has potential
benefits for the patient. A positive test result, for example, may al-
low early treatment and diet control to prolong life. A negative re-
sult could rule out HIV, leading the physician to explore other
causes and treatments. But the benefits are finely balanced against
the potential drawbacks. The most promising treatment,
zidovudine (also known as AZT), currently is not indicated for early
nonsymptomatic HIV, and its cumulative effects are highly toxic." 8
The value of an HIV test, therefore, is a matter of personal judg-
ment for the patient.
2. Management of Parenteral or Mucous Membrane Exposures.-As
discussed above, if HCPs sustain parenteral or mucous membrane
exposures to blood or bodily fluids, they run only a small risk of
HIV transmission. The CDC recommends that the source patient
116. Gillon, Testing for HIV Without Permission, 294 BRIT. MED. J. 821, 822-23 (1987).
117. CDC Recommendations: Testing, supra note 114, at 513. It is clinically appropriate
to test for HIV if the patient has "symptoms such as generalized lymphadenopathy; un-
explained dementia; chronic, unexplained fever or diarrhea; unexplained weight loss; or
diseases such as tuberculosis as well as sexually transmitted diseases, generalized
herpes, and chronic candidiasis." Id.
118. Carpenter & Mayer, Advances in AIDS and HIV Infections, 33 ADVANCES IN INTERNAL
MED. 45. 65-68 (G. Stollerman ed. 1988) (The most common toxicity is a suppression of
hematopoiesis, resulting in the need for one or more transfusions in more than a third
of patients.). Zidovudine is thought by some to be potentially effective in new cases of
HIV infection. See La Fon, Lehrman & Barry, Prophylactically Administered Retrovir in Health
Care Workers Potentially Exposed to the Human Immunodeficiency Virus, 158 J. INFECTIOUS Dis-
EASES 503, 503 (1988). Clinical trials to assess the efficacy of Zidovudine in asymptom-
atic patients are currently proceeding.
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be informed of the incident and tested for HIV after consent is ob-
tained.!' 9 Knowing the serologic status of the source patient, how-
ever, is of no clinical benefit to the HCP. Any transmission of HIV
already has occurred and knowledge of a patient's HIV status will
not alter that fact. Yet, HCPs who are exposed to bodily fluids claim
the right to know in order to ease the burden of uncertainty. There
may be some psychological benefit of discovering the patient's sero-
logic status, but even that benefit is uncertain. If the patient tests
positive, the HCP's anxiety will, if anything, be increased even
though the risk of transmission is less than one percent.' 20 If the
patient tests negative, the HCP still is advised to seek medical evalu-
ation and testing if the patient is in a high risk group for HIV. Be-
cause of the "window" period (the time between infection and the
development of a detectable antibody),' 2 1 source patients who test
negative still may be infectious.' 22 Thus, reliance on a negative test
result may lead to false assurances.
Many state legislatures, recognizing the concern of HCPs, spe-
cifically require notification of an HIV-positive test following a par-
enteral or mucous membrane exposure.' The CDC,' 24 and most
states that have legislated in the area of HIV testing,' 25 have not
recommended or authorized testing without consent.' 26 Given the
absence of any clear health benefit to the HCP, the value of compel-
ling the patient to be tested would be difficult to establish.
3. Prevention and Control of HIV Transmission in the Community.-
The CDC does not recommend "routine" screening of general hos-
pital patients. It does recommend, however, counseling and routine
119. CDC: Preventing Transmission in the Workplace, supra note 67, at 685.
120. As to the risks of seroconversion following a parenteral exposure to HIV-con-
taminated blood or bodily fluids, see Marcus, supra note 32, at 1119-20, 1122 (conclud-
ing that the risk of infection after exposure to blood of seropositive patient is low).
121. See supra notes 103-105 and accompanying text.
122. See CDC Recommendations: No. 2S, supra note 1, at 316.
123. Several state legislatures authorize or require disclosure of a patient's HIV-posi-
tive status following a parenteral or mucous membrane exposure of an emergency
worker (California, Delaware, Florida, Idaho, Illinois, Kentucky, New Hampshire, Texas,
Washington, and Wisconsin) or an HCP (Colorado, Delaware, Florida, Idaho, Illinois,
Kentucky, New Hampshire, Texas, Washington, and Wisconsin). See Gostin, supra note
95.
124. See CDC Recommendations: No. 2S, supra note 1, at 317.
125. See Gostin, supra note 95.
126. Two exceptions are Colorado and Maine, which allow for testing of patients
without consent after a needle-stick accident. Id. In Maine this can occur only after a
court order. ME. REv. STAT. ANN. tit. 5, § 19203-A(4) (1988). See also Holthaus, Consent
Advised Before AIDS-Antibody Tests, HosPITALS, July 20, 1988, at 40-4 1.
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HIV testing for a number of categories of persons who engage in
high risk behaviors. 27 But even here the CDC recommends testing
only with the person's informed consent.'
There is, therefore, little support for compulsory screening
even for prevention and control of HIV transmission. The reason
for the lack of support is the paucity of evidence that compulsory
testing would protect the public from viral transmission. It is as-
sumed sometimes that people will make more rational decisions
about behavior changes if they are informed of their serological sta-
tus. This is an assumption that has yet to be substantiated. There is
still insufficient behavioral research to prove that knowledge of sero-
positivity influences behavior at all. Even if such knowledge did in-
fluence behavior, it is difficult to predict in which direction the
behavior would move. Will those informed that they are seroposi-
tive altruistically refrain from high risk behavior, or will they act
more dangerously because there is little left to lose? The available
evidence thus far indicates that counseling, not necessarily testing,
is helpful in reducing unsafe behavior." 9
Counseling for behavior change is a highly personal matter.
The patient must be the one to decide voluntarily whether to com-
bine testing with counseling.' 30
B. Involuntary Testing
Those who call for routine testing of hospital patients seldom
define what is intended by the term.' 3 ' Some have used the term
"routine testing" to mean that all patients, or a certain category of
patient, should be tested as a matter of course, unless they state a
127, The CDC recommends "routine" testing of the following groups: persons who
may have a sexually transmitted disease, intravenous (IV) drug users, persons who con-
sider themselves at risk, women of childbearing age with identifiable risks, prisoners,
and prostitutes. CDC Recommendations: Testing, supra note 114, at 511-13.
128. Id. at 511.
129. See generally Becker & Joseph, AIDS and Behavioral Change to Reduce Risk: A Review.
78 AM. J. PUB. HEALTH 394 (1988); Fineberg, Education to Prevent AIDS: Prospects and
Obstacles, 239 Sci. 592, 594-96 (1988); McCusker, Stoddard, Mayer, Zapka, Morrison &
Saltzman, Effects of HIV Antibody Test Knowledge on Subsequent Sexual Behaviors in a Cohort of
Homosexually Active Men, 78 AM.J. PUB. HEALTH 462 (1988).
130. For arguments against compulsory testing to protect the public health, see gen-
erally Gostin, Screeningfor AIDS: Efficacy, Cost, and Consequences, 2 AIDS & PUB. POL'vJ. 14
(1987); Gostin & Curran, AIDS Screening, Confidentiality and the Duty to Warn, 77 AM.J. PUB.
HEALTH 361 (1987); Gostin, Curran & Clark, supra note 41.
131. The CDC does recommend consent prior to "routine" testing. CDC Recommenda-
tions: No. 2S, supra note 1, at 317.
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particular objection.13 2 Such routine testing that did not inform
each person in advance that an HIV test would be performed and
did not require prior consent, however, clearly would be an involun-
tary procedure. Where patients are unaware that an HIV test will be
given, their consent is fraudulently obtained. 133
Some HCPs argue that obtaining consent to draw blood and to
do routine serologic tests is sufficient in law, without any need to
obtain specific consent for an HIV test.'3 4 HCPs already feel
overburdened by informed consent requirements and see no need
for an additional consent. After all, the practice in medicine for
many years has been to perform a whole battery of blood tests with-
out obtaining consent for each particular test. Moreover, the HCPs
contend that HIV testing has no possible adverse physical effects for
patients. The drawing of blood is a procedure with minimal risk,' 35
and once the blood is drawn, performance of another test on the
blood cannot harm the patient physically. These HCPs argue that
the law of informed consent does not apply to a test that poses no
physical risk and has as its sole adverse effect the negative societal
reactions to the test and the disease. Others go further and say that
the only reason we do not mandatorily test is that AIDS has become
a "politically protected" disease.'3 6
The law of informed consent in many jurisdictions lays down a
patient-oriented standard for the information that must be disclosed
by the physician.' 37 The doctrine of informed consent is based
132. This appeared to be the position of the Reagan Administration as enunciated by
the President's Assistant for Policy Development. Bauer, AIDS Testing, 2 AIDS & PUB.
POL'YJ. 1, 2 (1987).
133. See Gillon, supra note 116, at 823.
134. Testing without the patient's knowledge or consent is not often discussed in the
professional literature in this country, but a recent study did show that there is a consid-
erable amount of surreptitious HIV-testing in hospitals. See Henry, Willenbring &
Crossley, supra note 9, at 1821. In Great Britain, however, the professional AIDS litera-
ture has been dominated by a debate on whether specific consent to an HIV test is re-
quired or desirable in law. See generally Dyer, Testing for HIV, the Medicolegal View, 295
BRIT. MED. J. 871 (1987); Morris, AIDS Counselling and Informed Consent, 294 BRIT. MED. J.
839 (1987); Sherrard & Gatt, Human immunodeficiency Virus (HIV) Antibody Testing, 295
BIT. MED. J. 911 (1987). A similar debate has taken place in Canada. See generally
Frank, Goel, Coates, Harvey & Schiralli, Testing for HIV Infection: Ethical Considerations
Revisited, 139 CANADIAN MED. A.J. 287 (1988) (the authors believe the risk to the patient
is the most significant factor in deciding when to test for HIV).
135. The only physical risk of drawing blood involves minor bruising or, rarely,
infection.
136. See Bauer, supra note 132, at 2.
137. See, e.g., Canterbury v. Spence, 464 F.2d 772, 780 (D.C. Cir. 1972), cert. denied,
409 U.S. 1064 (1973) (adopting Schloendorff); Harnish v. Children's Hosp. Medical
Center, 387 Mass. 152. 154-55, 439 N.E.2d 240, 242 (1982) (physician's failure to pro-
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upon the principle of autonomy, not paternalism.13 8 It is for pa-
tients to assess the value of a medical procedure and to determine
where their interests lie. If the adverse consequences would be in-
tolerable for the reasonable, prudent patient, that patient is entitled
to make the decision, however unwise the assessment appears in the
HCP's eyes.'I 9 "Although the probability of an adverse result may
seem slight to the physician ... he cannot withhold information if it
is relevant to a patient's ability to make an informed consent."' 4 °
Thus, courts require physicians to provide all information that a rea-
sonable patient would find relevant in making an informed decision
to undergo a medical procedure.' 4 1
Risks relevant or "material" to a patient's decision usually have
been confined to physical risks, rather than potential social harms.
If the purpose of the doctrine of informed consent is to place the
health care decision with the patient, however, then serious social
consequences are just as relevant for the patient as physical harms.
Reasonably prudent patients would regard the potential social con-
sequences of a positive HIV test as highly relevant to the decision to
undergo the test. An HIV test is a powerful indicator of a patient's
future health: scientists now believe that virtually all of those in-
fected with HIV will go on to have serious symptomatology, ranging
from severe immune deficiency and neurological dysfunction, to
death.'4 2 As with many medical tests that predict grave or fatal dis-
vide sufficient information to enable patient to give informed consent to procedure con-
stitutes professional misconduct); Schloendorff v. Society of New York Hosp., 211 N.Y.
125, 129-30, 105 N.E. 92, 93 (1914) ("Every human being of adult years and sound
mind has a right to determine what shall be done with his own body ... "). But see Dessi
v. United States, 489 F. Supp. 722, 730 (E.D. Va. 1980) (plaintiff failed to state a claim
where plaintiff did not establish sufficient causal link between lack of informed consent
and the injury); Watkins v. United States, 482 F. Supp. 1006, 1013 (M.D. Tenn. 1980)
(where no test for sensitivity existed, physician not negligent for failure to warn patient
sensitive to the drug concerning the drug's side effects).
138. Canterbury, 464 F.2d at 786 ("[T]he patient's right of self decision shapes the
boundaries of the [physician's] duty to reveal.").
139. Wilkinson v. Vesey, 110 R.I. 606, 624, 295 A.2d 676, 687-88 (1972) (patient's
right to make decision in light of own value judgment is very essence of freedom of
choice).
140. Hales v. Pittman, 118 Ariz. 305, 309, 576 P.2d 493, 497 (1987).
141. Canterbury, 464 F.2d at 781-82; Cobbs v. Grant, 8 Cal. 3d 229, 243, 502 P.2d 1,
10, 104 Cal. Rptr. 505, 514 (1972) (integral part of physician's overall obligation to the
patient is duty to reasonably disclose available choices with respect to proposed therapy,
as well as all dangers inherently and potentially involved in each choice); Harnish, 387
Mass. at 156-57, 439 N.E.2d at 243-44.
142. After 8-1/2 years more than 40% of infected individuals in studies have devel-
oped AIDS; a similar percentage has developed symptoms of HIV and is expected to
progress to AIDS. Statistics predict the possibility that virtually all will develop AIDS
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eases, some patients prefer to know the information, while others do
not.
Some patients bear an intolerable psychological burden when
informed that they are HIV-positive, particularly if they did not even
know they were being tested. A diagnosis of HIV-positivity clearly
involves the extremes of human emotion-panic, hatred, guilt, and
hopelessness. The intensity of these emotional responses to HIV
may be due at least partially to the virus's linkage with two of life's
most powerful experiences-sex and death. 4 '
A major study has indicated that men aged twenty to fifty-nine
with HIV in New York City are at least sixty-six times more likely to
commit suicide than the general population of that city.' 44 Due to
the devastating impact of the information that someone is HIV-posi-
tive, one of the highest risk periods for suicide during the course of
HIV infection is shortly after the patient learns of the diagnosis. A
number of anecdotal reports and psychiatric observations 45 sug-
gest that suicide can result from news of a positive test result. As
one commentator concluded, "Thus, the potential for severe, even
fatal, emotional consequences should heighten concerns about in-
appropriate HIV antibody testing without proper indications, in-
formed consent, or counseling. The risk of suicide is one more
reason that such tests should never be considered as 'routine.' ,41
Evidence of a condition that may lead to a grave or fatal illness
would be of great importance to anyone. Thrusting such unwanted
health information on a patient is unconscionable. Unless HCPs tell
their patients about the powerful emotional and psychological im-
pact of HIV-positive test results, the HCPs have not provided them
with all the information a reasonable patient would find relevant in
making an informed decision.
HCPs also should inform patients of the potentially serious so-
cial consequences of HIV-positive test results. Hospitals and other
within 13 years after initial infection. CONFRONTING AIDS UPDATE, supra note 31, at 35-
36.
143. Glass, AIDS and Suicide, 259J. A.M.A. 1369, 1369 (1988).
144. Marzuk, Tierney, Tardiff, Gross, Morgan, Hsu & Mann, Increased Risk of Suicide in
Persons with AIDS, 259J. A.M.A. 1333, 1335 (1988). These results are thought to be an
underestimate, given the difficulties of establishing both AIDS and suicide in official
death statistics. Id. at 1336-37. It is interesting to note that about 5 out of the 12 sui-
cides studied occurred in black or hispanic patients; that 5 of them expressed suicidal
intent to others; and that 25%7 of the suicides were committed by jumping from windows
in medical units of general hospitals. Id. at 1335.
145. Faulstich, Psychiatric Aspects of AIDS, 144 AM. J. PSYCHIATRY 551, 552-53 (1987).
146. Glass, supra note 143, at 1370.
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health providers cannot guarantee the confidentiality of HIV test re-
sults. Unauthorized disclosure of the results can cause ostracism
among family and friends, and can result in the loss of a job, a
home, a place in school, insurance, or other benefits.' 47 Once a per-
son's HIV status is in the medical record, it is often made available
to third-party payors. It also may be disclosed to employers, land-
lords, or insurers. In addition, numerous HCPs and auxiliary staff
may have access to the medical records, making it very difficult to
maintain the confidentiality of the record. These powerful social
and emotional consequences of an HIV test would be weighed care-
fully by any reasonably prudent patient.
Those in favor of "routine" HIV tests contend that the tests are
akin to the blood tests done for blood counts and chemistries. This
argument is fundamentally wrong. Such routine tests have no
equivalent personal and social consequences, and if they did have
such consequences, courts likely would require HCPs to obtain spe-
cific consent.' 48 Those in favor of "routine" HIV testing also mis-
takenly presume that routine testing for HIV is the standard of care
in the medical profession. In fact, the CDC recommends against
screening low risk groups such as general hospital patients as a mat-
ter of course.' 49
HCPs and hospitals can be found liable precisely because the
overwhelming consensus of professional opinion is that informed
consent is required before an HIV test. Policy statements from the
World Health Organization (WHO),' 5 0 the CDC,151 the Presidential
Commission on the Human Immunodeficiency Virus Epidemic
(President's Commission), 52 the AMA, 15  the American Hospital
Association (AHA), 154 the Institute Qf Medicine,' 55 and many other
leading professional organizations 156 have recommended that HIV
testing be performed only with fully informed consent and counsel-
ing. A standard of practice favoring informed consent and counsel-
147. Blendon & Donelan, supra note 110, at 1023-25.
148. See supra notes 137-141 and accompanying text.
149. CDC Recommendations: Testing, supra note 114, at 513.
150. See WHO Criteria for HIV Screening, supra note 114.
151. CDC Recommendations: No. 2S, supra note 1, at 317.
152. PRESIDENT'S COMMN, supra note 85, at 73-81.
153. AMA Board of Trustees, Prevention and Control of Acquired Immunodeiciency Syn-
drome: An Interim Report, 258J. A.M.A. 2097, 2101 (1987).
154. AHA REP., supra note 86, at iv-v.
155. INST. OF MED., NAT'L ACAD. OF ScI., CONFRONTING AIDS: DIRECTIONS FOR PUB-
LIC HEALTH, HEALTH CARE, AND RESEARCH 120-26 (1987); CONFRONTING AIDS UPDATE,
supra note 31, at 71-75.
156. See, e.g., Am. Co. of Physicians, supra note 86, at 465.
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ing has evolved through this large body of professional opinion. A
physician who fails adequately to inform and counsel a patient prior
to performing an HIV test is likely to be found negligent for failing
to conform with the professional standard of care.
In any event, in most American jurisdictions, the information an
HCP must give to a patient is not what is generally accepted in the
medical profession. Rather, HCPs must provide any information
that reasonably prudent patients would regard as material to the
health care decision they must make. Patients have a right of self-
determination in what is done with their blood, particularly when
the personal and social consequences are as severe as they are after
an HIV-positive test.
Courts have been highly consistent in clarifying when disclo-
sure is unnecessary. HCPs may dispense with disclosure when the
treatment is necessary in an emergency or is nonelective, 5 7 when
the patient is incompetent," 8 or when disclosure would be harmful
to the patient's psychological state.'5 9 Thus, the only valid reasons
for withholding relevant information are ostensibly for the patient's
therapeutic benefit..
It is impossible to conceive that an HIV test would fit into any
of the recognized categories where consent can be dispensed with; it
is not an emergency procedure, and it is not medically necessary or
life threatening. Further, asking patients if they want an HIV test is
hardly likely to be harmful to their psychological state. It certainly
would not be as harmful as performing the test without the patients'
knowledge and then informing them of the result.
Nevertheless, physicians sometimes believe that an HIV test is
beneficial to the patient for reasons of diagnosis or treatment. In
those instances, the HCP would have to explain the potential bene-
fits and risks to the patient, who would thenhave the final word on
whether to be tested.
The most telling argument in favor of disclosure and informed
consent is that the physician's motivation often is founded not upon
the patient's interests, but upon the interests of the physician. The
physician's ethical prerogative to practice medicine, even to perform
157. Keogan v. Holy Family Hosp., 95 Wash. 2d 306, 316-17, 622 P.2d 1246, 1253-54
(1980) (en banc).
158. See Meisel, The "Exceptions" to the Informed Consent Doctrine: Striking a Balance Be-
tween Competing Values in Decisionmaking, 1979 Wis. L. REV. 413, 439-53.
159. See, e.g., Canterbury v. Spence, 464 F.2d 772, 789 (D.C. Cir. 1972), cert. denied,
409 U.S. 1064 (1973); Harnish v. Children's Hosp. Medical Center, 387 Mass. 152, 157,
439 N.E.2d 240, 244 (1982).
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a simple blood test, lies in the fact that the patient stands to benefit
from the intervention. Physicians, of course, are permitted to act
for the benefit of others, provided they have the patient's informed
consent. The patient thus should at least be aware that the HCP
intends to use the blood for other purposes.
With involuntary HIV testing, however, the physician is pur-
porting to act for the benefit of others when there is no evidence
that others will in fact benefit and, moreover, the physician does not
have his or her patient's permission to do so. The physician might
argue that the ethical rules are bent only slightly because the patient
really is not harmed. But as one physician concluded: "We trade on
a deceit-a minor deceit but undoubtedly a deceit-if without either
explicit or implicit permission we start using our patients for the
benefit of others." 60
HIV testing without consent, therefore, is similar to medical re-
search not intended for the benefit of the patient. The legal and
ethical arguments in favor of informed consent, with special safe-
guards against abuse, are well rehearsed. There is perhaps no other
area of human endeavor where consent and autonomy matter more.
HIV testing without knowledge or consent goes against the very
purpose of the test: facilitating education and counseling. The pre-
vailing view is that patients should be informed of the potential con-
sequences of positive HIV test results; the possibility that the test
may be falsely positive; the behavior that is desirable to help prevent
further spread of HIV; the potential psychological impact; and the
locations where the patient can get personal, social, and financial
support in coping with the burden of the disease.' 6 ' By neglecting
to inform the patient that the test will be performed, HCPs fail to
provide the patient with the dignity and help that is now uniformly
accepted in the practice of medicine.
There are, moreover, serious ethical questions raised by failing
to treat the patient as a partner. How can HCPs inform their pa-
tients of HIV-positive test results when the patients never knew the
test was being performed in the first place? If the sole purpose of a
test were the physician's perceived safety, would the physician with-
hold a positive test result from the patient? To do so would be to
breach a duty of care toward the patient. Withholding relevant
health care information from a patient is untenable. The future di-
160. Gilion, supra note 116, at 823.
161. For a discussion of informed consent and counseling in relation to an HIV test,
see CONFRONTING AIDS UPDATh, supra note 31, at 71-74.
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agnosis, care, and treatment of the patient could be jeopardized if
the information were kept secret. Yet, to disclose the information,
as the physician must, would be to impose a potential burden of
stigma and discrimination on the patient, which the patient neither
invited nor even knew about.
The justifications for fully informed consent to HIV testing,
then, are that it respects a patient's autonomy and privacy in law, it
complies with the well-accepted clinical standards of care, and it
maintains the ethical integrity of the medical profession and the dig-
nity and worth of the patient.
IV. HIV SCREENING IN HOSPITALS: LEGAL
AND FINANCIAL BURDENS
Hospitals should have no interest in collecting sensitive health
care information when they can do nothing with that information to
improve HCP safety or patient care. This section will show that hos-
pitals would bear additional legal and financial burdens by imple-
menting screening programs.
Collection of information creates a demand for its use that
could result in legal liability for the hospital. Three potential ways
to use, or fail to use, the information could be costly for the hospi-
tal: discrimination against the patient by refusing care or providing
substandard care; unauthorized disclosure of the data to family, em-
ployers, landlords, or insurers; or failure to protect sexual and nee-
dle-sharing partners, who are in immediate danger of contracting
the patient's infection.
A. Refusal to Treat or Substandard Treatment
Surveys of physician attitudes have consistently shown that
many are fearful of, and some would even refuse to treat, AIDS pa-
tients."' Physicians are accustomed to having some freedom in de-
162. See, e.g., Gerbert, Majuire, Badner, D. Greenspan, J. Greenspan, Barnes & Carl-
ton, Changing Dentists' Knowledge, Attitudes and Behaviors Relating to AIDS: A Controlled Edu-
cational Intervention, 116 J. AM. DENTAL A. 851, 851 (1988) (education increased
willingness of health care professionals to treat AIDS patients); Kelly, St. Lawrence,
Smith, Hood & Cook, Stigmatization of AIDS Patients by Physicians, 77 AM. J. PuB. HALm
789, 789-91 (1987) (physicians exhibited harsh attitude judgments and much less will-
ingness to interact, even in routine conversation, with patients whose illness was identi-
fied as AIDS); Lewis, Freeman & Corey, AIDS-Related Competence of California's Primmy
Care Physicians, 77 AM. J. PUB. HEALTH 795, 795 (1987) (a majority of physicians inter-
viewed lacked AIDS-related knowledge and skills; competency was associated with physi-
cian's level of discomfort in dealing with homosexuals); Valenti & Anarella, Survey of
Hospital Personnel on Understanding of the Acquired Immunodfiinc-y Syndrome, 14 AM. J. INFEC-
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ciding who they will treat, and they are confronted for the first time
in a generation with the prospect that they may contract their pa-
tients' lethal infections. 63 Were physicians to have ready access to
the serologic status of all of their patients, there is a good chance
that some would refuse to treat them, or would provide substandard
treatment.' 64 As employers of these physicians, hospitals would
face legal liability.
The legal duty to treat patients with AIDS has been established
under common law, as well as under federal and state handicap stat-
utes. Once a patient is accepted for treatment by a hospital or phy-
sician a therapeutic relationship exists. After this health care
provider/patient relationship is established, the provider has a duty
not to abandon the patient. The general rule is that a pro-
vider/patient relationship continues until "it is terminated by mu-
tual consent; it is terminated by the patient; the services are no
longer needed; or the provider withdraws after reasonable notice to
the patient."' 6 5  AIDS patients characteristically need different
levels of care at different stages of the disease. During the time the
patient needs services, the hospital and the physician that have ac-
cepted the patient for treatment must continue that treatment. 6 6
A number of statutes designed to safeguard against discrimina-
tion of handicapped people probably would bar any refusal to treat
or provide adequate treatment, solely because the person had AIDS
or HIV infection. Most legal commentators have concluded that
TION CONTIROL 60, 62 (1986) (AIDS invoked anxieties even among well-educated physi-
cians and nurses). See also Faulstich, Psychiatric Aspects of AIDS, 144 AM. J. PSYCHIATRY
551, 554 (1987) ("Medical personnel must admit and confront their own concerns about
AIDS, perhaps involving unfounded beliefs about modes of disease transmission or neg-
ative attitudes toward caring for homosexuals and drug abusers."); Ponsford, AIDS in the
OR: A Surgeon's View, 137 CANADIAN MED. AJ. 1036, 1036 (1987) ("[some American
surgeons have resolved their dilemma by turning away patients who are HIV-positive or
who they think might be positive"). For an historical perspective on physicians' willing-
ness to treat infectious diseases, see Kim & Perfect, To Help the Sick: An Historical and
Ethical Essay Concerning the Refitsal to Care/or Patients with AIDS, 84 AM.J. MED. 135 (1988);
Zuger & Miles, Physicians, AIDS, and Occupational Risk: Historic Traditions and Ethical Obliga-
tions, 258J. A.M.A. 1924 (1987).
163. See R. BAYER, supra note 112.
164. See generally Albert, A Right to Treatmentfor AIDS Patients?, 92 DICK. L. REv. 743
(1988); Annas, supra note 59; Benesch & Homisak, The Duty to Treat AIDS Patients, 24
TRIAL 22? (May 1988); Brennan, supra note 3; Emanuel, Do Physicians Have an Obligation to
Treat Patients with AIDS, 318 NEW. ENG. J. MED. 1686 (1988).
165. Annas, supra note 59, at 845 (emphasis in original).
166. See supra note 164; see also infra notes 169-180 and accompanying text. During a
period when no harm will accrue to the patient, however, the hospital or physician prob-
ably may terminate the relationship.
44 MARYLAND LAW REVIEW [VOL. 48:12
federal and state handicap laws apply to persons who are, or are
perceived to be, infected with HIV. 167 Section 504 of the Rehabili-
tation Act of 1973 (the Rehabilitation Act) provides that "[n]o
otherwise qualified handicapped individual... shall solely by reason
of his handicap, be . . . subjected to discrimination." '68
Until recently, it was not clear that a person with HIV was
"handicapped" within the meaning of the Rehabilitation Act be-
cause of a controversial Justice Department memorandum' 69 and
the express refusal of the Supreme Court to decide the issue. °70 A
1987 amendment to the Rehabilitation Act, however, makes, it clear
that persons with a currently infectious disease or infection, includ-
ing HIV, are handicapped if they do not "constitute a direct threat
to health or safety" and are able "to perform the duties of the
167. See Kushen, Asymptomatic Infection with the AIDS Virus as a Handicap Under the Reha-
bilitation Act of 1973, 88 COLUM. L. REV. 563, 565 (1988); Mitchell, Employment Discrimina-
tion and AIDS: Is AIDS a Handicap Under Section 504 of the Rehabilitation Act?, 38 U. FLA. L.
REV. 649, 670 (1986); Pabst, Protection of AIDS Victims from Employment Discrimination Under
the Rehabilitation Act, U. ILL. L. REV. 355, 378 (1987). See generally Hentoff, The Rehabilita-
tion Act's Otherwise Qualified Requirement and the AIDS Virus: Protecting the Public From AIDS
Related Health and Safety Hazards, 30 ARIZ. L. REV. 571 (1988); O'Connor, Defining "Handi-
cap"for Purposes of Employment Discrimination, 30 ARIz. L. REV. 633 (1988); Parmet, AIDS
and the Limits of Discrimination, 15 LAW, MED. & HEALTH CARE 61 (1987); Sagot-Diaz, Em-
ployment Discrimination Against AIDS Victims: Rights and Remedies Available under the Federal
Rehabilitation Act of 1973, 39 LAB. L.J. 148 (1988).
168. 29 U.S.C. § 794 (Supp. IV 1986).
169. Prior to the Supreme Court's decision in School Bd. of Nassau County v. Arline,
480 U.S. 273, reh'g denied, 107 S. Ct. 1913 (1987). the justice Department held the opin-
ion that Section 504 of the Rehabilitation Act of 1973 (the Rehabilitation Act) did not
apply to persons with HIV since they could not be regarded as handicapped. See
Cooper, Application of Section 504 of the Rehabilitation Act to Persons with AIDS,
ARC or Infection with the AIDS Virus (June 23, 1986) (available from Office of Legal
Counsel, Department ofJustice, Room 5224, 10th St. & Pennsylvania Ave., N.W., Wash-
ington, D.C. 20530). Although the Supreme Court in Arline did not reach the issue of
the Rehabilitation Act's applicability to AIDS, 480 U.S. at 282 n.7, the Court did rule
that the government could not use the artificial distinction between infection and disease
as a basis for discrimination. Id. at 282. The Justice Department recently changed its
opinion, saying that the Rehabilitation Act does apply to persons with HIV. See
Culvah6use Jr., Application of Section 504 of the Rehabilitation Act to HIV Infected
Individuals (Sept. 27, 1988) (available from Office of Legal Counsel, Department ofJus-
tice, Room 5224, 10th St. & Pennsylvania Ave., N.W., Washington, D.C. 20530).
170. Arline, 480 U.S. at 282 n.7 (Section 504 could apply to a teacher with tuberculosis
(TB) if she posed no health hazard to children and others in the school). For further
analysis of the Supreme Court's decision in Arline, see Frome, School Board of Nassau
County v. Arline: A Basis for AIDS Antidiscrimination Suits, 19 U. WEST L.A. L. REv. 203
(1987); Lipshutz, Arline: Real Protection Against Discriminationfor Society's New Outcasts?, 17
STETSON L. REv. 517 (1988); Pankow, AIDS and the Rehabilitation Act After School Board of
Nassau County v. Arline, 21 CREIGHTON L. REV. 943 (1988); and Wasson, AIDS.Discrimina-
tion Under Federal, State, and Local Law After Arline, 15 FiA. ST. U.L. REV. 221 (1987), case-
note, School Board v. Arline: Will AIDS Fit the Mold? 41 ARK. L. REv. 639 (1988).
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job."'' Moreover, the lower courts have consistently held that
HIV-related impairments, including asymptomatic HIV infection,
are covered under the Rehabilitation Act.' 72 Former President Rea-
gan also directed all federal agencies to protect HIV-infected em-
ployees against discrimination. 7 -
The major problem with the Rehabilitation Act is that it applies
only to programs receiving federal financial assistance, and does not
extend into the private sector. All fifty states and the District of Co-
lumbia, however, have handicap statutes similar to the federal Reha-
bilitation Act.' 74 In all but five jurisdictions 75 handicap statutes
prohibit discrimination against private as well as public employees.
Many state courts, human rights commissions, and attorneys general
have expressly found that the handicap laws apply to AIDS or HIV
infection. 76
To underscore the importance of protecting persons with HIV
from discrimination, many states and municipalities have enacted
AIDS-specific statutes or ordinances. These state antidiscrimination
statutes characteristically target specific areas such as employ-
ment, 177 housing,17 8 or insurance.'7 9 Some local ordinances, such
as those in San Francisco and Los Angeles, are even more compre-
hensive, prohibiting discrimination in business establishments, pub-
lic accommodations, educational institutions, and city facilities or
services. 180Hospitals and physicians, therefore, would risk liability if they
171. Civil Rights Restoration Act of 1987, Pub. L. No. 100-259, 102 Stat. 28 (1988).
172. See, e.g., Chalk v. Orange County Dep't of Educ., 832 F.2d 1158, 1158 (9th Cir.
1987), Ray v. School Dist. of DeSoto County, 666 F. Supp. 1524, 1536 (M.D. Fla. 1987);
Local 1812, American Fed'n of Gov't Employees v. United States, 662 F. Supp. 50, 54
(D.D.C. 1987).
173. R. Reagan, Statement Announcing a Federal Human Immunodeficiency Virus
Epidemic Action Plan, reprinted in 24 WEEKLY COMPILATION OF PRESIDENTIAL DOCUMENTS
990 (Aug. 2, 1988).
174. Gostin, supra note 95.
175. The five jurisdictions are Alaska, Arkansas, Delaware, Idaho, and Michigan. Gos-
tin, supra note 95.
176. See, e.g., Shuttleworth v. Broward County, 639 F. Supp. 654, 656 (S.D. Fla. 1986).
177. States having such antidiscrimination employment statutes include California,
Florida, Hawaii, Maine, Massachusetts, Oregon, Texas, Washington, and Wisconsin.
Gostin, supra note 95.
178. States having such antidiscimination housing laws include California, Florida,
and Hawaii. Gostin, supra note 95.
179. States having such antidiscrimination insurance statutes include California, Dela-
ware, District of Columbia, Florida, Hawaii, Illinois, Maine, New Hampshire, New York,
Oregon, Rhode Island, West Virginia, and Wisconsin. Gostin, supra note 95.
180. See Gostin & Ziegler, A Review of AIDS-Related Legislative and Regulatory Policy in the
United States, 15 LAw, MED. & HEALTh CARE 5, 13-14 (1987).
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used HIV-related information to refuse treatment to persons who
are, or are perceived to be, HIV-positive. This provides another
powerful reason for hospitals to avoid actively collecting this
information.
B. Confidentiality
Individuals infected with HIV, whether HCP or patient, are
concerned with maintaining the confidentiality of their health status.
HIV infection is associated with sexual practice and drug use, uni-
versally regarded as personal and sensitive activities. In addition,
the majority of people infected with HIV in the United States are
members of groups that are traditionally disfavored. Even before
the AIDS epidemic, gays and intravenous (IV) drug users were sub-
ject to persistent prejudice and discrimination.' AIDS brings with
it a special stigma. Attitude surveys show that even though most
Americans understand the modes through which HIV is spread, a
significant minority still would exclude those who are HIV-positive
from schools, public accommodations, and the workplace.' Unau-
thorized disclosure of a person's serologic status can lead to social
opprobrium among family and friends, as well as loss of employ-
ment, housing, and insurance.
HCPs and patients in hospitals, therefore, have strong grounds
for desiring personal privacy and confidentiality of their serologic
status'. Their cooperation with hospital and public health authori-
ties is dependent upon their expectation of privacy. Two serious
consequences of a policy of routine screening are that patients may
choose to avoid or postpone treatment, and HCPs may seek to
evade any testing requirement. Trust in and compliance with many
public health programs depend upon the maintenance of a person's
privacy.
Hospitals that systematically collect the HIV status of patients
or HCPs will find it very difficult to keep that information confiden-
tial. Numerous staff members, third-party payors, and others have
access to a hospital's health records. Even elaborate schemes devel-
oped by some hospitals, such as keeping separate AIDS records or
having a special coding or marking for AIDS records, have not over-
come the problem. Further, if hospitals keep a systematic record of
181. See generally Note, The Constitutional Status of Sexual Orientation: Homosexuality as a
Suspect Classification, 98 HARV. L. REV. 1285 (1985) (arguing that lesbians and gays should
be protected as a suspect class under the fourteenth amendment).
182. Blendon & Donelan, supra note 110, at 1024.
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HIV-positive patients or HCPs there will be strong pressures to re-
lease lists of names. Pressure to release names of those who test
HIV-positive could come from many sources: the public health de-
partment may desire the information for purposes of medical sur-
veillance and contact tracing; state boards of medical licensure or
patients themselves might seek to know which physicians are HIV-
positive; persons engaged in litigation might seek this information
to establish that they contracted HIV, for example, from a surgeon
or patient, or as the result of a blood transfusion. 83
Thus, by collecting sensitive health care data, hospitals may find
themselves under great pressure to disclose that information. An-
other possibility is that the information may be disclosed intention-
ally or carelessly by persons with access to medical files. If a
person's HIV status is disclosed intentionally or negligently without
the person's consent, a hospital could face substantial liability.
Such liability could arise under the common law or by stat-
ute.18 In most states courts have held that there is an enforceable
common-law duty inherent in a physician/patient relationship to
keep sensitive health care information confidential. 185 Failure to
maintain confidentiality is actionable at law and can result in
damages. 186
Remarkably, almost half the states in America now have special
statutes protecting the confidentiality of AIDS-related informa-
tion. '8 1 Most of these statutes broadly protect the identity of indi-
viduals seeking an HIV test, their seropositive status, all
unauthorized disclosures of the medical record, and information ob-
tained from interviews for the purposes of partner notification.' 88
Common-law and statutory requirements across the country,
183. A Texas court of appeals, for example, has held that HIV- positive blood donors'
records could be subject to court-ordered disclosure in the interests ofjustice. Tarrant
County Hosp. Dist. v. Hughes, 734 S.W.2d 675, 680 (Tex. Ct. App. 1987). Compare
Rasmussen v. South Fla. Blood Servs,, Inc., 500 So. 2d 533, 538 (Fla. 1987) (privacy
interests of blood donors and society's interest in maintaining strong volunteer blood
donations system outweighed victim's interest).
184. See Dickens, Legal Limits of AIDS Confidentiality, 259J. A.M.A. 3449, 3449 (1988)
(concerning laws that mandate the maintenance of strict confidentiality of medical data);
Stein, AIDS and the Confidentiality of Medical Records, I I J. AMBULATORY CARC MGMrr. 39, 40
(1988); Stryker & Natale, The Legal Limits of AIDS Confidentiality, 260 J. A.M.A. 3273,
3273-74 (1988) (letters to the editor replying to Dickens article).
185. See, e.g., Alberts v. Devine, 395 Mass. 59, 69, 479 N.E.2d 113, 120 (1985). See also
Dickens, supra note 184, at 3449.
186. See Dickens, supra note 184, at 3449.
187. See Gostin, supra note 95.
188. Id.
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therefore, require hospitals to maintain strict confidentiality of
health care information. By systematically collecting this data with-
out any clear benefit, hospitals would needlessly open themselves
up to potential liability.
C. Duty to Protect Sexual and Needle-Sharing Partners
Were hospitals to collect HIV-related information, they also
could face liability for failing to notify a patient's sexual or needle-
sharing partner of the risk of contracting the virus. While the duty
to keep personal information confidential is strict, it may be overrid-
den by other duties owed by the holder of the information. Courts
have held that HCPs must disclose confidential information to those
for whom the patient poses a foreseeable danger.' 8 9 Some courts
have established a duty to protect, 9 0 while others have merely
carved out an exception to the principle of confidentiality making it
lawful to disclose confidences when necessary to protect third par-
ties in foreseeable danger.' 9 '
The duty or power to protect usually applies only to identifiable
persons at risk and not to "statistically probable victims.- ' 92 Ac-
cordingly, a reasonably specific and high degree of potential harm,
such as with a known sexual or needle-sharing partner, is required
189. This theory of liability stems from Tarasoff v. Regents of the Univ. of Cal., 17
Cal. 3d 425, 551 P.2d 334, 131 Cal. Rptr. 14 (1976), where the court sustained a cause
of action against a psychologist who did not warn a third party of his patient's intention
to murder her. The patient later murdered the third party. The court concluded that
once a therapist determines or should have determined that a patient poses a serious
danger to another, that therapist bears a duty to warn the potential victim. Id. at 430,
551 P.2d at 340, 131 Cal. Rptr. at 20. Accord Lipari v. Sears, Roebuck & Co., 497 F.
Supp. 185, 193 (D. Neb. 1980). See also Hermann & Gagliano, AIDS, Therapeutic Confiden-
tiality, and Warning Third Parties, 48 MD. L. REV. 55 (1989).
190. Lipari v. Sears, Roebuck & Co., 497 F. Supp. 185, 193 (D. Neb. 1980) (under
Nebraska law, a psychotherapist owes an affirmative duty to third persons to whom the
psychotherapist's patient poses an unreasonable risk of harm); Cairl v. State, 323
N.W.2d 20, 26 (Minn. 1982) (if duty to warn exists at all, the duty requires warning only
insofar as latent dangers posed to identifiable, specific persons); McIntosh v. Milano,
168 N.J. Super. 466, 489-90, 403 A.2d 500, 511-12 (1979) (a mental health professional
may have a duty to protect a potential victim of his or her patient if the patient poses a
probable danger to the person); Peck v. Counseling Serv. of Addison County, 146 Vt.
61, 68, 499 A.2d 422, 427 (1985) (mental health agency had a duty to warn that the
outpatient had threatened to burn down his parents' barn).
191. Alberts v. Devine, 395 Mass. 59, 68-69, 479 N.E.2d 113, 119-20 (1985) (recog-
nizing exception to duty of confidentiality where there is serious danger to the patient or
others); Simonsen v. Swenson, 104 Neb. 224, 228-29, 177 N.W. 831,933 (1920) (physi-
cian was not liable for disclosure of confidential information where he in good faith and
with reasonable care believed it was necessary to prevent spread of disease).
192. Cairl, 323 N.W.2d at 26 n.9.
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before there is a duty or a power to protect. 9 3
HCPs, therefore, may have a legal obligation in some jurisdic-
tions to protect a sexual or needle-sharing partner of a patient with
HIV infection. The HCP may fulfill that obligation by, first, advising
the patient of the nature of the infection, how it is spread, and pre-
cautions that can be taken. If, however, the patient is unlikely to
heed the advice, the HCP may have to notify third parties of the
foreseeable risk, which could necessitate further questioning of the
patient anot contact tracing.
It is not at all clear whether current doctrine actually would im-
pose a legal duty to protect sexual or needle-sharing partners of pa-
tients with HIV. There is reason to believe that successful litigation
may be extremely difficult because of the absence of precedent in
cases dealing with infectious diseases,' 9 4 and because establishing
that an HCP's failure to warn caused a person to contract HIV would
be very difficult.115 In addition, the steps that an HCP must take to
193. For example, in Gammill v. United States, 727 F.2d 950 (10th Cir. 1984), a
United States Army physician failed to inform a nearby community of an outbreak of
hepatitis. The plaintiffs, who contracted the disease, claimed that the Army had a duty
to disclose the risk to the public through the county health department. The court held
that there was no legal duty to warn the general public; before a duty to warn arises, the
physician must be aware of specific risks to particular persons vulnerable to hepatitis. Id.
at 954. Thus, a reasonably specific and high degree of potential harm is required before
the court will dispense with the obligation of confidentiality. See also Derrick v. Ontario
Comm. Hosp., 47 Cal. App. 3d 145, 153, 120 Cal. Rptr. 566, 571 (1975) (hospital has no
duty to warn members of the general public that one of its patients being released is
suffering from a contagious disease).
Some courts do not require that there be an identifiable victim to establish liability.
See, e.g., Lipari, 497 F. Supp. at 194 (in order to establish liability there must be foresee-
ability to an injured party or a class of persons of which the injured party was a member).
Rather, liability is established by the existence of foreseeable danger to any member of a
targeted class of people. Id. at 194-95. If a patient threatens violence and possesses the
means to carry it out, a duty to protect may arise.
194. The duty to protect predates Tarasoff v. Regents of the Univ. of Cal., 17 Cal. 3d
425. 551 P.2d 334, 131 Cal. Rptr. 14 (1976). Most of the precedent for Tarasoff was from
old infectious disease cases. See, e.g., Davis v. Rodman, 147 Ark. 385, 391, 227 S.W. 612,
641 (1921) (duty of physician to advise family members and others liable to be exposed
of patient's typhoid fever); Skillings v. Allen, 143 Minn. 323, 324, 173 N.W. 663, 664
(1919) (knowing plaintiff's child had scarlet fever, physician negligently advised plain-
tiff's wife that it was safe to visit the child); McIntosh v. Milano, 168 N.J. Super. 466,
475, 403 A.2d 500, 509 (1979) (dictum that doctor has duty to warn third parties against
possible exposure to infectious disease). While these cases are often said to have estab-
lished a duty to warn, they do not firmly support such a proposition. Most of these cases
involved misdiagnosis of an infectious condition so that family members were placed at
risk, or misinformation so that the physician incorrectly informed the family that the
disease was not infectious. The cases, therefore, do not squarely concern a breach of
confidence, since the family already knew the patient was suffering from a disease.
195. HIV infection usually produces no symptoms until several years after the infec-
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fulfill the duty to protect have never been established clearly by the
courts: does the duty only require counseling of the infected pa-
tients themselves, or does it necessitate tracing intimate contacts
and providing a warning?
HCPs, then, are caught in an ethical dilemma between the duty
to maintain confidentiality and the duty to protect sexual and nee-
dle-sharing partners of patients with HIV infection. The very fact
that the law has not provided clear guidance to HCPs on whether
their primary responsibility is to their patient or to third parties
gives additional reason to pause before systematically collecting and
acting upon this sensitive information.
D. Financial Considerations
In addition to the legal burdens of implementing HIV screen-
ing programs in health care settings, such screening also creates sig-
nificant .financial burdens. For example, screening requires the
administration and interpretation of initial and confirmatory screen-
ing procedures. These entail significant expenses for the adminis-
tration of laboratories, test equipment, and personnel.'9 6
Moreover, screening only indicates that a person is positive at a par-
ticular point in time. Thus, to be certain of identifying all infected
cases, periodic retesting would be required. The cost for each case
found in a low risk population, such as all patients entering a hospi-
tal, would be prohibitively expensive. The substantial costs of in-
vesting in such a screening program must be measured against the
equally large expenditures needed for research, education, counsel-
ing, and treatment.
The costs of performing the HIV tests alone would be signifi-
cant for hospitals that implement "routine" screening. But the
costs would become even greater if the program complies with CDC
requirements of pre- and post-test counseling in every case. Any
hospital embarking on such a program of screening would have to
be prepared to spend a substantial amount of funds with no clear
tion is contracted. For example, almost no cases of AIDS occur during the first 2 years
after infection is discovered, but after 8-1/2 years, approximately 40% of infected cases
develop AIDS. CONFRONTING AIDS UPDATE, supra note 31, at 35-36. By the time a per-
son develops serious symptoms, it will be exceedingly difficult to go back and demon-
strate that an identifiable patient transmitted the infection, and that an identifiable HCP
could have prevented it by giving a warning. This point becomes even more obvious
when a victim has to demonstrate that one particular sexual or needle-sharing partner,
among many, was the cause of the infection.
196. See Merlis, Acquired Immunodeficiency Syndrome (AIDS): Health Care Financing & Serv-
ices, 1B87219 CONG. REs. SERV. 3 (Jan. 4, 1988).
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expectation of impeding the spread of HIV or assisting patients in
the hospital.
V. SUMMARY AND CONCLUSIONS
Legislative proposals for screening in health care settings have
been introduced in several states.' 97 Such proposals often focus on
hospital patients and not on HCPs. Hospital patients undergoing
seriously invasive procedures, however, also run a risk of exposure
to HIV. Thus, an analysis of proposals for mandatory screening
should be applicable to both populations. At the very least, when
the government wishes to compel hospital patients to be tested, it
should justify why the same reasoning does not apply to HCPs.
The sole legitimate objective of systematic mandatory screening
in health care settings is to reduce the spread of HIV. Introduction
of such a screening program would be justified only if (l) the risk of
transmission in the setting is significant, (2) screening would de-
crease the risk, and (3) the human and economic costs of screening
were not disproportionate to the benefit to be achieved. The goal of
this article has been to demonstrate that mandatory HIV screening
in health care facilities would not meet any of these criteria.
Considerable evidence now demonstrates that health care set-
tings do not pose an unusually high risk of transmission of HIV that
would justify mandatory screening.' 98 The reasons for this conclu-
sion are that hospital patients are predominantly the elderly and the
very young, the two catagories least likely to harbor HIV; routine
medical and nursing procedures do not create a significant risk of
exposure to HIV; and even percutaneous or mucous membrane ex-
posure usually does not lead to seroconversion. Indeed, the risk of
occupational exposure to HIV in health care settings is well below
the risk HCPs already incur for HBV. The possibility of HBV infec-
tion is far higher and the aggregate mortality from occupational ex-
posure is far greater than for HIV.'99 Yet, there have been no
serious proposals for HBV screening, even after many documented
cases of transmission both to HCPs and patients.20 0
197. See generally Gostin & Ziegler, A Review of AIDS-Related Legislative and Regulatory
Policy in the United States, 15 LAw, MED. & HEALTh CARE 5 (1987).
198. See supra notes 65-66 and accompanying text.
199. Id.
200. See generally Gerety, Hepatitis B Transmission Between Dental or Medical Workers and
Patients, 95 ANNALS INTERNAL MED. 229 (1981); Leftauetal, Transmission of Hepatitis B with
Resultant Restriction of Surgical Practice, 255 J. A.M.A. 934 (1986); Shaw, Barrett & Hamm,
Lethal Outbreak of Hepatitis B in a Dental Practice, 255 J. A.M.A. 3260 (1986).
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Even if the risk of AIDS transmission in health care settings
were considerably greater than research has thus far indicated,
mandatory screening still would be justifiable only if it significantly
decreased the rate of transmission. As this article has indicated,
however, screening would not decrease occupational exposure; in-
deed, such exposure could increase with screening. There is no
data to suggest that if HCPs knew patients were seropositive they
could take any additional precautions to reduce the risk of con-
tracting HIV. In fact, in most cases of occupational exposure to
date, HCPs already knew the patients were infected.
Moreover, screening merely indicates whether, at a particular
time, a patient has antibodies to HIV. Although the ELISA is highly
sensitive, 0 1 it is well recognized that there is a window of time,
ranging from weeks to months, when a person may be infected but
not develop the antibody. This "window period" may be considera-
bly longer in some cases, lasting for a year or more. 0 2 Screening
programs, therefore, would detect most-but not all-cases of in-
fected patients. If HCPs were falsely reassured that a patient was
seronegative, they might not follow necessary infection-control
guidelines when working with that patient. If a patient tests nega-
tive for HIV antibodies, it would be a serious error in judgment to
relax efforts to protect against accidental exposure to blood. Ac-
cordingly, the information provided by the test should not alter high
standards for infection control.
Finally, any marginal public health benefit of a "right to know"
a person's serologic status would be outweighed by the substantial
human and economic costs of a screening program. The law of in-
formed consent almost certainly applies to HIV-antibody tests
because of the significant impact on the individual.2"' Studies indi-
cate that positive HIV test results can cause severe psychological
distress, including an increased risk of suicide, 2 and can result in
public ostracism and discrimination.20 5 In addition, HCPs have a
professional obligation to obtain permission for HIV antibody tests
because of the critical importance of pre- and post-test
counseling.2 0
Widespread HIV screening could be prohibitively expensive.
201. For a discussion of ELISA, see supra note 109.
202. See supra note 104 and accompanying text.
203. See supra notes 137-142 and accompanying text.
204. See supra notes 144-145 and accompanying text.
205. See supra note 147 and accompanying text.
206. See supra notes 150-161 and accompanying text.
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Periodic testing would be required to ensure that accurate and cur-
rent results were obtained. The costs of laboratory work and careful
counseling before and after tests were administered would have to
be borne by hospitals that already are financially overstretched. °7
Systematic collection of sensitive HIV test results also could re-
sult in liability for health care providers. Hospital employees may
give substandard treatment, or even refuse to treat, positive-testing
patients, in violation of federal and state statutes protecting handi-
capped persons.208 In addition, hospitals could not guarantee the
confidentiality of the information, thus exposing themselves to po-
tential liability under common-law doctrine and modern AIDS con-
20fidentiality statutes. 09 In some jurisdictions, hospitals and HCPs
might be under a legal obligation to notify sexual or needle-sharing
partners at risk of infection. Failure to warn in such cases could re-
sult in liability.210
Compulsory screening in health care facilities, then, would not
be an efficacious public health policy: there is little documented risk
of occupational transmission; knowledge of a patient's HIV-an-
tibody test result would be unlikely to further decrease the already
low risk; and screening would pose wholly disproportionate psycho-
logical and social burdens on the individual, and financial burdens
on the HCP and the health care facility. This conclusion is shared
by each of the major public health authorities that have considered
the subject: the WHO,2 2 the CDC,212 the AHA,21 s the AMA,214
and the American Nurses' Association.2 5
Health care facilities need a sensible, effective alternative to
HIV screening. The best alternative is universal precautions, which
already are recommended by the CDC21 6 and OSHA. 2 17 Such a pol-
icy would significantly decrease the risk of occupational exposure to
HIV and other blood-borne viruses, and would limit the potential
liability of HCPs and hospitals. The precautions would do so with
207. See supra note 196 and accompanying text.
208. See supra notes 162-180 and accompanying text.
209. See supra notes 181-188 and accompanying text.
210. See supra notes 189-195 and accompanying text.
211. See generally WHO Criteria for HIV Screening, supra note 114.
212. See generally CDC Recommendations: No. 2S, supra note 1.
213. Am. Hosp. Ass'n, Advisory Committee on Infections, Statement on Employee
Protection for Blood-Borne Diseases (June 25, 1987).
214. See AMA Board of Trustees, supra note 153.
215. ANA Reaffirns Supportfor CDC Guidelines, Hospital News, National Capitol Area,
July 1987, at 6.
216. See supra notes 67-78 and accompanying text.
217. See supra notes 80-84 and accompanying text.
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little or no impact on patients' rights to autonomy, confidentiality,
and nondiscriminatory treatment. If we choose, instead, to follow
the shrill voices of both HCPs and patients for a "right to know," we
will ultimately undermine trust in our health care institutions with-
out any public health utility.
